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ABSTRACT 
 
As the pharmaceutical industry moves towards larger protein-based therapeutics over 
chemically synthesized small molecules, there are increasing demands for parallel advancement 
in the technologies used for quality control of these biologically-derived products 
(biopharmaceuticals). This work describes the implementation of mass spectrometry (MS)-based 
methods in three areas where MS is well-positioned to fulfill unmet analytical needs. First, time-
resolved electrospray ionization hydrogen-deuterium exchange (TRESI-HDX) and ion mobility 
spectroscopy (IMS) MS were used to study conformational dynamics in transient Cytochrome c-
lipid interactions. MS was also implemented for proteomic characterization of in-process and 
purified samples from acellular Pertussis vaccines. Further development of a targeted MS 
method is described for quantitation of two residual protein toxins, adenylase cyclase toxin 
(ACT) and dermoneucrotic toxin (DNT), and a glycopeptide, tracheal cytotoxin (TCT) from 
Bordetella pertussis. Collectively, the results highlight advancement in the application of 
structural and quantitative proteomics for more effective characterization of next generation 
biopharmaceuticals. 
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Chapter 1: Introduction 
1.1 – Mass Spectrometry 
1.1.1 Current Perspectives 
Mass spectrometry (MS) as technique for measuring the mass of molecules has existed 
for over 100 years, starting with the separation of Ne isotopes using a “parabola spectrograph” 
by Nobel Prize winner J.J Thomson in 1913.1,2 Mass spectrometers have developed into 
remarkably versatile analytical instruments with a unique ability to transfer molecules into the 
gas phase and accurately measured molecular masses according to their specific mass-to-charge 
ratio (m/z). Until the late 1980s, MS was primarily used to study low molecular weight chemical 
compounds, as no technique existed to transfer intact biomolecules into the gas phase. This 
changed when K. Tanaka and J. B. Fenn developed Nobel prize winning soft ionization 
techniques, matrix-assisted desorption ionization (MALDI)3 and electrospray ionization (ESI).4 
These soft ionization techniques together with fundamental improvements to ion sampling and 
detection have increased the analytical power of MS in an unprecedented range of applications. 
Today, mass spectrometers have evolved into a backbone technique in the analytical sciences, 
with widespread use in the fields of biology,5 medicine,6 and chemistry7. 
1.1.2  Electrospray Ionization 
Electrospray ionization (ESI) is the soft-ionization technique of choice for online analysis 
of solution-phase biomolecules. Amendable to coupling with high-performance liquid 
chromatography (HPLC)-based separation techniques, ESI also facilitates hyphenated HPLC-MS 
workflows which are particularly advantageous for complex biological samples.8 In a typical ESI 
source, ions are generated by passing a solution containing the analyte(s) of interest through a 
thin metal capillary. A high electric potential (2-6 kV) at the tip of the capillary causes formation 
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of a Taylor cone. In positive ion mode, charging occurs via protonation resulting in accumulation 
of positively charged particles at the tip of the Taylor Cone.9 As the ejected parent droplets fly 
towards an oppositely charged plate inside the mass spectrometer, solvent evaporation in the gas-
phase causes the droplets to shrink. The charge-to-volume ratio in the droplet increases until 
columbic repulsion destabilizes the structure resulting in droplet fission.10 Parent and offspring 
droplets undergo numerous evaporation/jet fission cycles as shown in Figure 1.1. Described by 
the Rayleigh equation, the charge limit prior to a fission event (QRy) is based on the electrical 
permittivity (ε0), surface tension (γ), and radius of the droplet (R).11–13  
QRy = 8π(ε0γR3)1/2 
  Electrospray ionization is thought to occur via two mechanisms, namely the 'Charged 
Residue model’ (CRM)14, and 'Ion Evaporation model’ (IEM)15. With considerable experimental 
evidence to support the validity of both, there is a consensus that small analytes form droplets 
with very small radii (< 10 nm diameter). Favouring IEM, these small droplets gain charges as 
they enter the gas phase and solvent is evaporated.16 In contrast, larger molecules such as folded 
proteins are thought to follow CRM and undergo multiple fission/evaporation cycles until the 
remainder of the solvent evaporates leaving a 'residue' of charge. Of relevance to ‘bottom-up’ 
MS workflows for protein analysis, peptides from proteolytic digests may fall in the grey area 
between the IEM and CRM mechanisms of ionization, directly impacting absolute MS signal 
response.17 Generally, IEM predicts more efficient ionization of peptides with less 
hydrophobicity-driven surface; a trend that holds up for small hydrophobic peptides in-
solution.18 Larger peptides are thought to mimic the ionization process for small, globular 
proteins with post-ionization declustering and ion transmission having the greatest influence on 
observed signal intensity.17,18 
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Figure 1.1. Schematic depiction of an ESI source operated in positive mode. Analyte 
solution passes through a metal spraying nozzle whose tip is held at a high voltage (2-6 kV). 
Electric potential created at the capillary tip causes the dispersion of the sample solution creating 
a Taylor cone, resulting in ejection of positively charged parent droplets due to overpowering of 
columbic forces. During transit towards the an oppositely charged curtain plate in the mass 
spectrometer, interplay between solvent evaporation and sequential jet fission events results in 
reduction in droplet size until naked charged analytes are transferred into the mass spectrometer. 
Adapted from Banerjee & Mazumdar, 2012.10  
1.1.3 Nano Electrospray Ionization 
Conventional ESI involves pressure-driven flow rates in the 1-100 µL/min range for 
capillary LC and from 0.1 µL/min to 1 mL/min for conventional flow LC. Modern electrospray 
sources incorporate in-line heating and collateral gas flows to hasten evaporation during the 
ionization process.19,20 Despite these additions, a substantial fraction of analytes are lost due to 
lack of desolvation during the ESI process. An alternative approach involves the use of lower 
flow rates (typically 100-500 nL/min), achieved via nano-liquid chromatography (nanoLC) and 
narrow-bore pulled tip emitters. Droplets formed under these ‘nanospray’ conditions are 
significantly smaller (hundreds of nm), and thus ionize in tens of µs instead of the hundreds of 
ms with conventional ESI flowrates.21 The decrease in solvent flow also enables reduced sample 
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consumption and softer ionization conditions. These advantages together with boosted in 
baseline sensitivity lead to the first major application of nanoESI with hyphenated nanoLC 
coupled ESI-MS methods (nanoLC-MS) proteomics.22,23 
1.1.4 Hybrid Mass Spectrometers 
Mass spectrometers usually consist of an ion source, mass analyzer, and data processing 
electronics. Instrument platforms are increasingly being built with dual MALDI/ESI source 
compatibility and electron multiplier or time to digital converter (TDC) detectors. Therefore, it is 
often the type of mass analyzer that is the major differentiator between instrument platforms, and 
their suitability for downstream applications. 
All mass analyzers separate ions based on their mass-to-charge (m/z). However, each 
mass analyzer has unique properties pertaining to mass range, analysis speed, resolution, 
sensitivity, ion transmission, and dynamic range. Ion trap (IT), Orbitrap, and ion cyclotron 
resonance (ICR) mass analyzers separate ions based on their m/z resonance frequency. Excelling 
at high resolution tandem mass spectrometry (MS/MS), these trap-based instruments are often 
limited in dynamic range of detection.24 Quadrupoles (Q) use m/z stability and oscillating 
electrical fields to selectively stabilize the paths of ions passing through a radio frequency (RF) 
field between 4 parallel rods. Configurations such as the triple quadrupole (QqQ) contain two 
mass selecting quads in parallel. QqQ instruments provide particularly robust quantitation and 
specificity when used with low-energy collision-induced dissociation (CID), but with lower 
resolution than trap-based analyzers. Lastly, time-of-flight (TOF) analyzers use an electric field 
to accelerate the ions through a common potential and measures the time taken to reach the 
detector. With a theoretically infinite mass range, TOFs provide the fastest scan times and are 
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particularly useful for analysis of large biomolecules; however, are limited in precursor 
selectivity and quality of MS/MS fragment ion analysis.25 
Hybrid mass spectrometers are denoted by the combination of mass analyzers and mass 
filters in order of appearance along the ion path. Configurations such as the triple quadrupole 
(QqQ), quadrupole linear ion trap (QLIT or LTQ), Quadruple Time of Flight (QTOF), TOF-
TOF, and quadrupole-Orbitrap, are increasingly common; each having their own distinct 
analytical characteristics.26 For the coming work, the focus will be on the quadrupole-Orbitrap 
MS for proteomics (Figure 1.2), and the QTOF for structural MS applications (Figure 1.3).  
 
Figure 1.2. Schematic representation of the Q Exactive High Field (HF) Quadrupole-
Orbitrap Mass Spectrometer. Ions entering from electrospray ionization (ESI) source are 
focused by radio frequency (RF) and a bent flatapole, removing neutrals from the ion beam. A 
mass selective quadrupole enables selection of ions at a specified m/z range towards storage in 
Curved Linear Trap (C-trap) or fragmentation cell. Fragments ions are generated in the high-
energy collision induced dissociation (HCD) cell and detected in the High Resolution Accurate 
Mass (HRAM) Orbitrap mass analyzer. Adapted from Scheltema and colleagues, 2014.27 
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Figure 1.3. Schematic representation of the Synapt G1 High Definition Mass 
Spectrometer. A traveling-wave (T-wave) ion guide focuses incoming ions with trapping and 
release of parent ions for mass selection in the quadrupole.  Mass selected ions are then trapped 
prior to the ion gate of the ion mobility (IMS) cell which separates analytes based on their cross-
section as they collide with inert gas. Ions exiting the IMS are focused again by a T-wave ion 
guide as they are transferred into time-of-flight (TOF) analyzer. Fragmentation by collision-
induced-dissociation (CID) can be performed before mobility in the trap, or after mobility in the 
transfer region of the instrument.  Ion mobility separation adds an additional dimensionality, 
enabling detection of ions by mass and size. Adapted from Pringle and colleagues, 2007.28 
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1.2 Mass Spectrometry in Structural Biology 
1.2.1 Existing Biochemical Techniques for Studying Protein Structure and Dynamics 
The ability to identify proteins and to determine structure-function relationships is central to 
the life sciences. The amino acid sequences of proteins serve as a link between their coding 
genes and their physiological roles as components in complex cellular regulatory networks. 
Before to the emergence of genomics, chemical or enzymatic assays were most commonly used 
to characterize highly purified proteins.  Direct or indirect evidence of protein structure was 
generally deduced through low-resolution spectroscopic techniques including circular dichroism, 
intrinsic protein fluorescence, UV-Vis, and infrared (IR) spectroscopy.29 
With increased performance and versatility of the instrumentation, MS emerged as the 
technique of choice for determining amino acid sequence of peptides and proteins by the mid-
1990s.30 Despite the close relationship between protein sequence and structure, adoption of MS 
was significantly slower for higher order structure characterization. Though often hindered by 
the upfront challenges associated with getting a protein crystal, X-ray crystallography remained 
the classical approach for protein structure determination.31 However, several advancements in 
instrumentation in the 1980s and 1990s made nuclear magnetic resonance (NMR) amenable for 
structural characterization of proteins in addition to small molecules.31 The main advantage of 
NMR over X-ray crystallography is the ability to analyze proteins under more physiological 
conditions, thereby retaining the structural flexibility observed in-solution. Of note, the hydrogen 
deuterium exchange (HDX) methodology, described for MS-based applications in the 
subsequent section, can also be analyzed by NMR. Nonetheless, HDX NMR is restricted by the 
size limitations of NMR (typically less than 25 kDa), and is generally insensitive to transient, yet 
biologically-relevant protein conformations occurring on sub-second timescales.31 
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1.2.2 Hydrogen Deuterium Exchange 
HDX is a structure-dependant chemical labelling reaction that was first observed by Kaj 
Ulrik Linderstrøm-Lang using ultracentrifugation32, and further explored by Englander et al. in 
HDX measurements to single amide resolution by NMR.33 In 1993, HDX was first coupled to 
LC-MS, providing the foundation the “bottom-up” HDX-MS workflow that is most commonly 
used today.34 Briefly, the protein was reacted in excess deuterium resulting in the exchange of 
covalently attached, backbone amide hydrogens with deuterium atoms in solution. The reaction 
was quenched by lowering the pH with acid then digested using pepsin. Cool acidic conditions 
(pH 2.5, 0°C) were used to minimize back exchange in amide backbone positions. The labelled 
peptides were further separated by LC and deuterium incorporation calculated from the mass 
shift detected by MS.35 
 
Figure 1.4. Exchangeable amide and side-chain hydrogens in a peptide. Exchangeable 
backbone amide hydrogens are depicted in teal and the labile side-chain protons are depicted in 
salmon-pink color. Adapted from Oganesyan and colleagues, 2018.35 
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In a protein, rapid isotopic exchange can occur with any hydrogen bound to sulfur, 
oxygen or nitrogen. Amide hydrogens, found uniformly across the peptide backbone, are the 
most commonly monitored in HDX experiments for probing subtle changes in higher order 
structure (Figure 1.4). At physiological pH, exchange is base-catalyzed where the backbone 
amide is deprotonated by nucleophilic attack of a deuterium hydroxide forming an amidate ion. 
The amidate ion is subsequently reprotonated with a deuterium atom from the deuterium oxide 
(D2O) solution (Figure 1.5).  Cooling the reaction to 0°C and reducing the pH to 2.5 decreases 
the rate of amide hydrogen exchange by approximately 4-5 orders of magnitude compared to pH 
7 and 23°C. Consequently, these “quenching conditions” are typically used to minimize loss of 
the deuterium label (i.e. back-exchange) in HDX-LC-MS experiments.34,36  
 
 
Figure 1.5. Mechanism of base-catalyzed backbone amide hydrogen-deuterium exchange 
(HDX). At neutral pH, HDX is primary driven by base catalysis where nucleophilic attach by 
deuterium hydroxide deprotonates a covalently attached hydrogen at the peptide amide position. 
Subsequent re-protonation of the amidate ion by D2O leaves an isotopically heavy deuterium 
atom that can be differentiated by MS. 
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The rate of exchange is dependent on four main factors: intramolecular hydrogen 
bonding, solvent accessibility, pH and temperature, with the later two controlled experimentally. 
The method can be applied 'globally' to give information on the overall flexibility of proteins or 
'locally' at the peptide level. Spatial localization arises from differential deuterium uptake due to 
varying degrees of structural protection. Replacement of a hydrogen atom (H) with a heavier 
deuterium isotope (D) results in a mass increase of one unit per exchange event that can be 
detected as a shift of the mass spectrum. Since longer peptides have more exchangeable 
backbone amide hydrogens, results are typically expressed as a percentage of deuterium uptake 
(% uptake) for the number of deuterated backbone amide hydrogen positions relative to the total 
number of exchangeable hydrogens (# exchangeable hydrogens = # residues - # proline residues 
-1 for the N-terminal amide).32,37 
In both global and local experiments, the mass spectrometer monitors deuterium uptake 
as a function of time, either on the intact protein (global) or individual peptide (local) level. In 
stably folded protein regions, the rate limiting step for HDX is the solvent abstraction of the 
proton. Under physiological conditions where F and U are the folded and unfolded states, 
respectively, folded proteins exhibit EX2 kinetics whereby they rate of refolding is much greater 
than the rate of unfolding (k-1 >> k2). Consequently, the observed rate of deuterium uptake is 
dominated by the effects of hydrogen bonding and solvent accessibility. Tightly folded regions 
with α-helices and β-sheets are generally less dynamic, and therefore exhibit reduced uptake 
compared to loops or other disordered protein regions.38,39 
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1.2.3 Time-Resolved Hydrogen Deuterium Exchange 
Conventional HDX as described in 1.2.2 is a powerful tool for studying a variety of 
systems including monoclonal antibodies, antibody-drug conjugates, protein-protein interactions, 
and protein-ligand interactions.40 However, the timescale of conventional HDX is generally 
limited to steady-state equilibrium conditions with labelling times from 10 seconds to several 
hours. In cases were the protein structure is very dynamic, such as intrinsically disordered 
proteins and transient interactions, functionally-relevant intermediate structures are often missed. 
To circumvent this limitation for studying pre-steady state conditions, millisecond HDX-MS 
techniques were developed using stopped-flow rapid mixing devices coupled to ESI-MS.41,42 The 
early version of the capillary-based mixing device was a fixed length mixer which required 
physically changing the reaction capillary to obtain different timepoints. For improved 
consistency, flow rates could be also be adjusted to alter the reaction time; however, this caused 
considerable pressure fluctuations and made it challenging to obtain stable, time-resolved results 
(Figure 1.6).43  
In 2003, the ‘fixed mixer’ apparatus evolved to include two concentric capillaries 
forming an adjustable reaction chamber that allowed for continuous-flow reactions on a 
millisecond timescale.41 Reaction times were adjusted by withdrawing the inner capillary to 
increase the dead-volume between the mixing point and the onset of ESI for introduction to the 
MS (Figure 1.7). This approach, known as Time-Resolved Electrospray Ionization Mass 
Spectrometry (TRESI-MS) was later incorporated onto a microfluidic chip in the Wilson lab at 
York University44 with on-chip quenching and proteolytic digestion for local HDX-MS 
analysis.45 
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Figure 1.6. Schematic of the first time-resolved electrospray ionization MS device using a 
capillary-based mixer. Syringes carrying the reactants of interest meet and react within a static, 
or fixed, mixing tee. Reaction is controlled by the length of the reaction capillary between the 
mixing tee and electrospray source where reaction time (t) is proportional to the length of 
capillary (x). Adapted from Konermann et al. 1997.46 
Figure 1.7. Continuous-flow time-resolved electrospray ionization device featuring two 
concentric capillaries and adjustable reaction volumes. Solution flowing through the inner 
capillary exits through a notch produced 2 mm from the inner capillary tip and mixes with the 
solution flowing through the outer capillary. Multiple time points achieved by manual or 
automated pullback of the inner capillary relative to the outer capillary. Adapted from Wilson 
and Konermann, 2003.41 
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1.2.4 Ion Mobility Spectroscopy 
Ion Mobility Spectrometry (IMS) is an analytical technique that separates gas phase ions 
based on their size and shape. The power of the approach is rooted in its speed and compatibility 
with LC-MS for isolating isobaric species with different ion conformations. While IMS-MS does 
not provide localized structural information, it has the advantage of being sensitive to co-existing 
populations that would otherwise overlap on a mass-to-charge (m/z) spectrum. 
IMS is based on the time it takes for ions to travel through a gas-field chamber, called a 
drift tube, upon which a weak electric field has been applied. Collisions with neutral buffer gas 
delay ion movement, giving rise to different mobilities. Ions with a larger surface area will 
experience more collisions and thus take longer to transverse the drift relative to smaller, more 
compact ions of the same mass and charge.47 IMS-MS results contain an additional degree of 
dimensionality with arrival times corresponding to each species detected on the mass spectrum 
(Figure 1.8). This arrival time distribution reflects the conformational range of the analyzed 
species, and can be converted into collision cross-sections for ions in the gas-phase.48 Sharp 
peaks typically reflect a single protein conformation whereas broader peaks can represent 
multiple conformational states.49 
The Waters Synapt G1 High Definition MS was the first commercial MS instrument to 
incorporate hardware for IMS-MS.47 The travelling-wave IMS cell contains a series of stacked 
ring ions guides that builds on the principles of drift tube mobility separation described above. 
Briefly, application of alternating phases of RF voltage and superimposed direct current (DC) 
voltage creates a “wave” which differentiates ions of different mobilities. Ions with higher 
mobility are able to “surf” the wave more effectively thereby reducing their transit time through 
the IMS cell.28,49   
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Figure 1.8. Schematic representation of IMS-MS. Ions enter a drift tube with an applied 
electric field and migrate at different drift velocities to the detector.  Measurements of arrival 
time distributions reflect the conformational range of the examined species. Adapted from Gili 
Ben-Nissan and Michal Sharon, 2018.50  
 
1.2.5 Applications at Protein-Membrane Interfaces 
Many cellular signalling events are controlled by the selective recruitment of protein 
complexes to membranes surfaces. For membrane proteins found at this critical interface, biological 
activity often depends on transient changes in protein conformation due to binding interactions with 
lipids in membrane bilayers.51,52 Structural studies of membrane proteins by conventional 
techniques such as NMR and X-ray crystallography have advanced thanks to the development of 
small, versatile model membrane systems including micelles, bicelles and liposomes.53–58 Though 
detailed, the pictures captured by these methods typically reflect the populated, ground-state structure, 
and not transient protein conformations such as those induced by peripheral interactions with 
phospholipids in membrane bilayers.59,60 Structure-function studies of peripheral membrane 
proteins also contend with the natural heterogeneity of biological membranes, and the influence 
of different lipid head groups on the polarity of membrane surfaces.61–63 
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1.3 – Proteomics 
The availability of full genome sequences for thousands of organisms has greatly 
contributed to the growth of MS-based proteomics. Rather than focusing on particular protein 
family, proteomics aims to provide a top-down view of all proteins in an organism, including 
post-translational modifications (PTMs) and protein-protein interactions. This level of global 
protein information about the proteome can be combined with other “big data” techniques such 
as genomics64, lipidomics65, transcriptomics66, and metabolomics67 for a systems biology 
approach to understanding an organisms’ life cycle.52 
1.3.1 “Top-down” versus “Bottom-up” Approaches to Protein Analysis  
MS has emerged as a core tool for large-scale protein analysis, owing to rapid 
advancements in LC separation, data acquisition, and bioinformatics analysis. MS-based 
characterization of proteins is divided into two types of analysis: “top-down” referring to intact 
proteins, or “bottom-up” approaches in which peptides are released via enzymatic digestion 
(proteolysis) prior to LC-MS analysis. Bottom-up analysis of a protein mixture is commonly 
referred to as “Shotgun proteomics”. Coined by the Yates lab68,69 due to analogy to shotgun 
genomic sequencing, shotgun proteomics provides an indirect measure of a protein, making use 
of tandem mass spectrometry (MS/MS) sequencing of peptides derived from proteolytic 
digestion.70 Bottom-up workflows are typically more sensitive than top-down approaches, 
offering more efficient ionization and less division of signal among different charge states. 
Whereas shotgun proteomics workflows employ enzymatic digestions that can be applied 
universally across sample types, top-down methods are typically restricted to relatively pure 
samples, due to limits in fractionation and fragmentation capabilities.71 
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1.3.2 Shotgun Proteomics 
1.3.2.1 Nano-liquid chromatography (nanoLC) 
While conventional LC-MS techniques typically make use of 2.1 mm internal diameter 
(i.d) columns and flow rates of 100-1000 µL/min, nanoLC benefits from downsizing to sub-100 
µm columns and nanoflow rates (< 500 nL/min) with a theoretical gain in absolutely sensitivity 
of approximately 1000-fold.72,73  This boost in baseline sensitivity is rooted in improved 
ionization efficiency and fewer co-eluting peptide precursors. The benefits of nanoLC come at 
the expense of less robust system performance and longer acquisition times. For shotgun 
proteomics where the goal is to maximize proteome coverage, these trade-offs are outweighed by 
the ability to identify more proteins in complex samples. Therefore, nanoLC remains a fixture 
proteomics where upmost sensitivity is required.23  
1.3.2.2 Proteolytic Digestion 
In a typical bottom-up proteomics experiment, protein mixtures are enzymatically 
digested with a protease producing a peptide mixture. This digestion step is most commonly 
performed using trypsin due to its efficient and specific cleavage at arginine and lysine residues. 
The resulting tryptic peptides are generally short for good sequencing via collision induced 
fragmentation. Having a basic arginine (Arg) or lysine (Lys) residues at the C-terminus also 
makes tryptic peptides ideal for chromatographic separation by reverse phase high pressure 
liquid chromatography (RP-HPLC). Nevertheless, it has become apparent that trypsin, like all 
other proteases, can skip a cleavable residue resulting in so‐called missed cleavages.74 Using 
only one protease also limits the number of identifiable post-translational modifications (PTMs) 
with different extents of PTM coverage based on the type of modification, amino acid residue, 
and position in the protein sequence.75 
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In response to these limitations, there has been emergence of complementary proteases 
for LC-MS preparation (Table 1.1).76 For example, working in a Trypsin/Lysozyme C (Lys-C) 
mix has been shown to overcome the proteolytic resistance of tightly folded proteins, reduce the 
number of missed cleavages, and prevent tryptic autolytic activity.77 To maximize coverage, 
protocols up to six proteases have been implemented including the following alternatives to 
trypsin: chymotrypsin, LysN, AspN, GluC, ArgC and pepsin (albeit with non-specific cleavage 
properties).76 
Table 1.1. Complementary proteases for sample digestion in bottom-up proteomic analyses. 
Protease Specificity Optimal pH  Approximate MW 
Trypsin Carboxyl side of Arg and Lys pH 8.0 23.3 kDa 
Asp-N Amine side of Asp and Cys pH 6.0 - 8.5 24.5 kDa 
Glu-C Carboxyl side of Glu and Asp pH 4.0 - 7.8 29.0 kDa 
Lys-C Carboxyl side of Lys pH 8.5 28.0 kDa 
Arg-C Carboxyl side of Arg pH 7.5 - 8.5 26.5 kDa 
1.3.2.3 Data-dependent acquisition (DDA)  
After enzymatic digestion, peptides are separated by RP-HPLC followed by shotgun MS 
analysis (Figure 1.9). This is mostly commonly performed via a data dependant acquisition 
(DDA) method in which the “topN” most abundant precursors are selected for collision induced 
fragmentation. The generated tandem mass spectra (MS/MS) spectra contain fragment ions 
corresponding to the sequence of the tryptic peptide (Figure 1.10). Peptide identification is 
achieved using bioinformatics search tools such as Mascot62, Sequest78 and MS Amanda79 which 
compare experimental MS/MS spectra against theoretical peptide MS/MS spectra generated from 
in silico digestion of a protein database .The identity of 100s-1000s of proteins can be inferred 
by matching identified peptides to protein sequences (based on sequence homology). 
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Figure 1.9. Shotgun proteomics workflow for protein identification by nano-liquid 
chromatography tandem mass spectrometry (nanoLC-MS/MS). Protein sample is digested 
with trypsin and is separated on a reverse phase chromatographic column coupled to a tandem 
MS instrument (top panel). The MS measures the precursor mass of each peptide, selecting a 
pre-defined number of the most intense parent ions for fragmentation by collisional activation.  
The output is a MS/MS spectrum containing fragments ions corresponding to a peptide sequence. 
A protein database is theoretically digested with trypsin, resulting in a list of all possible peptides 
and their associated MS/MS spectra. A comparison between experimental and theoretical 
MS/MS spectrum enables assignment of peptide sequence from which peptide and protein 
identity can be inferred within a level of confidence. Adapted from Armengaud, 2012.32 
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Figure 1.10. Example of a CID/HCD fragment ion (MS/MS) spectra for a tryptic peptide. 
‘y-ions’ correspond to fragments in the C to N-terminal direction whereas ‘b-ions’ sequence 
residues in from the N to C-terminus of the peptide.  Adapted from Ma and Johnson, 2012.81 
 
 
1.3.2.4 Limitations in Shotgun Proteomics Analyses 
Though providing a good global snapshot of proteins in a sample, shotgun proteomics 
methods are inherently limited in the breadth of coverage, reproducibility, and dynamic range of 
detection. Most biological samples contain a mixture of aqueous and membrane-associated 
proteins, spanning over 5-10 orders of magnitude in abundance.82 Despite ongoing 
improvements, MS instruments are only capable of up to 5-6 orders of magnitude of dynamic 
range.7 Furthermore, the most commonly used solution-based digestion workflows bias proteome 
coverage towards proteins which are water soluble, and hence enzymatically digestible. 
Therefore, many present-day proteome maps are missing protein sequences despite ongoing 
development efforts.83,84  
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Another limitation in shotgun proteomics is the data-dependant nature of precursor 
selection. Conventional DDA workflows favour detection of the most abundant proteins as they 
generate the most intense precursor peptide signals. For Orbitrap instruments which are the most 
commonly used platform in proteomics, dynamic range in the survey scan is further limited by 
the charge holding capacity of the curved linear ion trap (C-trap) prior to detection.26 
Consequently, peptides which co-elute with more intense features may not be selected for 
fragmentation, and thus will not be detected by a database search. While the dynamic range and 
reproducibility of fragmentation can be enhanced by using data-independent acquisition (DIA) 
strategies on quadrupole-Orbitrap hybrid instruments85,86, fundamentally a lack of MS detection 
using shotgun methods cannot be definitely linked to absence below a consistent LOD due to 
semi-stochastic precursor selection. This ultimately leaves shotgun MS with poor run-to-run 
reproducibility and limited capabilities beyond relative quantitative analyses, despite efforts to 
develop universal approaches for precursor-based quantitation.87 
1.3.3 Targeted Proteomics 
Limitations in DDA for absolute quantitation have propelled the development of targeted 
proteomic methods—namely, selected reaction monitoring (SRM), also known as multiple 
reaction monitoring (MRM) on triple quad MS instruments (QqQ), and parallel reaction 
monitoring (PRM) on quadrupole-Orbitrap MS platforms. As in bottom-up DDA workflows, 
proteins are enzymatically digested to peptides and analyzed by RP-HPLC. A key difference is 
the use of an inclusion list such that the sensitivity of the instrument is specifically harnessed for 
analytes of interest rather than the most abundant precursors. Targeted MS acquisitions methods 
provide the reproducibility that shotgun workflows lack, and facilitate absolute quantitation 
when coupled with appropriate internal standards.88 
 21 
 
 
Figure 1.11. Comparison of shotgun and targeted acquisition methods for proteomic 
analysis. Data-Dependent Acquisition (DDA) and Parallel Reaction Monitoring (PRM) 
workflows differ in how precursors are isolated for fragmentation. Using the most intense 
features as in a DDA workflow, results in a more comprehensive analysis whereas targeting 
precursors by PRM enhances sensitivity and enables absolute quantitation.  
 
In a targeted MS workflows, precursor ions are isolated using a quadrupole (Q1) and 
subsequently fragmented by collision induced dissociation (CID) or high-energy collision 
induced dissociation (HCD) creating sequence-specific b and y-ion fragment ions (Figure 
1.10).89 In a conventional targeted analysis performed on a QqQ MS instrument, the first and 
third quadrupole are used to selectively isolate pre-defined precursor-fragment ion pairs called 
transitions. Following fragmentation in the collision cell (2nd quadrupole), 3-5 abundant 
fragment ions per precursor are sequentially isolated by the 3rd quadrupole. The presence of the 
fragment ions transitions is monitored over chromatographic retention time via extracted ion 
chromatogram (XIC) traces which are subsequently used for quantition.90–92  
 
 22 
 
The speed and specificity from analyte-specific fragmentation patterns makes 
SRM/MRM workflows the gold standard for MS-based quantitation.93 Nevertheless, these 
targeted MS method on QqQ instruments require significant upfront development and a priori 
knowledge to define the precursor-fragment ion pairs for analysis. Additionally, SRM/MRM 
acquisitions are specific to fragment ions from targeted analytes. Consequently, acquisitions are 
effectively blind all other components in the sample, making it difficult to identify and account 
for potential matrix effects. 
1.3.3.1 Parallel Reaction Monitoring 
More recently, rising popularity of quadrupole-Orbitrap instrument platforms has led to 
emergence of parallel reaction monitoring (PRM) as an alternative quantitative MS method.94   
In PRM, the third quadrupole of the QqQ is substituted with a high resolution accurate mass 
(HRAM) Orbitrap mass analyzer, enabling parallel detection of all fragment ions via full MS/MS 
scans. PRM methods can also be combined with MS survey scans to enable evaluation of sample 
complexity and matrix effects using the total ion chromatogram (TIC) for a given sample. 
Analysis of precursor-fragment ion transitions is performed post-acquisition such that transitions 
can easily be refined in the event of background interference (Figure 1.12).  
Figure 1.12. Parallel Reaction Monitoring on an Orbitrap MS. Precursors isolated in the 
quadrupole are subject to fragmentation by HCD and are detected in an MS/MS spectrum by the 
Orbitrap. Post-acquisition analysis of extracted ion chromatograms (XIC) enables quantitation 
relative to a spiked internal heavy peptide standard.  
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1.3.3.2 Stabile Isotope Labelled Peptide Standards for Absolute Quantitation 
MS-based quantitation makes use of stable isotope dilution (SIL) for absolution 
quantitation. The principle is based on absolutely quantified heavy-labelled peptide standards, 
called AQUA peptides, which are spiked into the sample as internal standards.95 AQUA peptides 
are identical to their native peptide counterparts down to the base atoms. As a result, they have 
the same ionization efficiency and co-elute chromatographically. Presence of a 13C, 15N heavy 
labelled Arg or Lys at the C-terminus creates a mass shift to the endogenous peptides. Native 
peptide concentration is calculated from the ratio of unlabelled (native)-to-heavy peptide, and the 
known amount of spiked heavy peptide standard.96 
Selection of the surrogate peptide sequence for use with a matching AQUA peptide is 
arguably one of the most challenging, yet critical steps in developing of sensitive targeted MS 
assay.  Though there are several strategies for guiding surrogate peptide selection, most employ a 
priori knowledge of protein sequence combined with previously acquired data (usually from a 
shotgun proteomic analysis). Using this so-called data-driven strategy biases selection towards 
the most abundant peptides at the survey scan or MS1 level. However, MS1 intensity does not 
always translate into specificity and sensitivity at the fragment ion (MS2) level used in 
MRM/PRM quantitation. Furthermore, shotgun analysis of an individual sample provides no 
information on digestion kinetics, peptide stability or potential matrix effects; all critical 
attributes in a quantitative MS assay. As a result, there remains room for alternative approaches 
for surrogate peptide selection.  
 
 
 
 24 
 
1.4 Research Objectives 
The main objective of this work is the implementation of mass spectrometry (MS)-based 
workflows in emerging areas where MS is well-positioned to fulfill unmet analytical needs. 
Chapter 2 will focus on the application of structural MS techniques including travelling-wave ion 
mobility (IMS-MS) and time-resolved electrospray ionization hydrogen-deuterium exchange 
(TRESI-HDX-MS) for characterization of conformational dynamics in protein-lipid interactions. 
The use of these sensitive structural MS techniques will facilitate mechanistic understanding of 
electrostatic interactions involved in the recruitment of a peripheral membrane protein to a 
phospholipid bilayer. Shifting away from biochemical interactions, Chapter 3 will focus on 
strategies for contending with complex, lipid-containing samples for more complete coverage of 
membrane-associated proteins in shotgun proteomics workflows. Lastly, Chapter 4 will highlight 
a synthetic peptide screening approach in the development of a targeted nanoLC-MS/MS method 
for absolute quantitation of residual toxins in vaccines samples from Bordetella pertussis 
(B.pertussis). Collectively, the highlighted workflows will contribute to enhanced 
characterization of biological systems with the end goal of accelerated biopharmaceutical 
development. 
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Chapter 2: Deciphering electrostatically-driven lipid binding modes in the 
cytochrome c-membrane interaction using structural mass spectrometry 
 
2.1 Introduction 
The interaction between 12 kDa Cytochrome c (Cyt c) and the inner-mitochondrial membrane 
represents a paradigm for the challenges associated with mechanistic studies of peripheral membrane 
proteins. Primarily known for its redox activity in the electron transport chain,97 release of Cyt c from 
the mitochondria to the cytosol is a critical first step in the initiation of mitochondrial-induced 
apoptosis.98–102 Cyt c’s pro-apoptotic function is rooted in its interaction with cardiolipin (CL), a 
negatively charged (anionic) phospholipid making up approximately 25% of lipids found in the 
mammalian mitochondrial membrane.103,104 When bound to CL, Cyt c makes use of H2O2 in the 
mitochondria to catalyse the oxidation of CL, which in turn decreases the strength of the CL-mediated 
Cyt c-membrane interaction.105 This peroxidase-induced detachment from the mitochondrial 
membrane enables Cyt c to release into the cytoplasm where it participates in apoptosome complex 
formation and downstream activation of caspases required for programmed cell death.101,106,107   
Since it was shown that CL-bound Cyt c acts a peroxidase in the early stages of apoptosis,108–
110 it has been thought that interactions with membrane phospholipids induce conformational changes 
in Cyt c enabling it’s functional shift from electron carrier to pro-apoptotic catalyst.110–112 Higher 
order structural characterization of Cyt c-membrane interactions (CD, FTIR and Raman) have shown 
loosening of the tertiary structure and disruption of the Met80-heme ligation upon binding to anionic 
phospholipids.113–116 In these structure-function studies, CL has generally been mixed with other 
phospholipids in liposomes in an attempt to mimic the composition of the inner mitochondrial 
membrane. Of the mitochondrial phospholipid classes, phosphatidylcholine (PC) is the most 
commonly used phospholipid in combination with CL.63, 64 Containing a primary amine bound to a 
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phosphate head group (Figure 2.1), PC lipids bear a positive charge and neutral pH, and thus are not 
expected to have significant electrostatic affinity for cationic Cyt c. Therefore, it has long been 
presumed that CL/PC lipososomes are suitable mimetics for studying role of CL in the the Cyt c-
membrane interaction.117 However, recent studies have shown Cyt c binding to zwitterionic 
phospholipids, including PC, with liposomes of varying acyl chain length and CL composition.119,120 
Consequently, the question of electrostatic involvement in the Cyt c-membrane remains a 
fundamental gap in our mechanistic understanding of Cyt c as peripheral membrane protein and its 
role in mitochondrial-induced apoptosis. 
 
Figure 2.1. Chemical structures of CL and PC phospholipids analyzed with Cyt c.  
A) 1', 3’-bis [1,2-dimyristoyl-sn-glycero-3-phospho]-glycerol (14:0 Cardiolipin), B) 1,2-
Dimyristoyl-sn-Glycero-3-Phosphocholine (DMPC), and C) 1, 2-Dihexanoyl-sn-Glycero-3-
Phosphocholine (DHPC). 
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Early work characterizing the phospholipid-mediated Cyt c-membrane interaction established 
two binding sites, namely the A-site and C-site, with differing affinities for negatively-charged 
phospholipids.121 The interaction at the A-site was proposed to be electrostatic in nature, involving 
positively charged residues (possibly at Lys72/Lys73), whereas the C-site was suggested to participate 
in hydrophobic interactions with one of the acyl chains of the phospholipid interacting with the highly 
conserved Asn52 residue.122–124 More recent experimental evidence has provided grounds for a 
more peripheral binding mechanism including two independently acquired time-resolved 
florescence energy transfer (TR-FRET) studies showing conformational interchange between 
extended and compact CL-bound conformers on the bilayer surface.125,126 Following a two-stage 
mechanism, the Cyt c-membrane interaction has been proposed to involve electrostatic forces for 
initial establishment, followed by activation of pro-apoptotic peroxidase activity.124 A summary of 
previously proposed modes of Cyt c – membrane association is shown in Figure 2.2. 
Functional studies of Cyt c have shown increased peroxidase activity at high CL/Cyt c 
ratios.110,118,127 Interestingly, examination of absorbance at 695 nm as a function of peroxidase activity 
showed no change in biological activity despite Met80-heme bond disruption at higher CL/Cyt c 
ratios.110 The lack of correlation between Met80-heme bond disruption and peroxidase activity 
suggests that CL-induced protein unfolding is not a prerequisite for peroxidase activity. This 
observation is further supported by NMR and FTIR measurements showing that Cyt c retains its 
secondary structure upon interaction with phospholipid membrane surfaces.111,116,128 Collectively, 
these results demonstrate that despite extensive structural characterization, understanding of the 
dynamics involved in the establishment of the Cyt c-membrane interaction remains limited. 
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Figure 2.2. Proposed modes of CL-mediated association of Cyt c with the membrane 
bilayer. Previously suggested models of the Cyt c-membrane  interaction  include insertion of 
the protein into the membrane129, acyl chain insertion into the protein121,122,124, and a peripheral 
insertion on the membrane surface with unfolding of the protein125,126. Adapted from Muenzner 
and Pletneva, 2014.114  
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To examine the basis for CL-specific functionality in the Cyt c-membrane interaction, the 
conformational dynamics of Cyt c were studied in the presence of anionic cardiolipin (CL) and 
cationic phosphatidylcholine (PC) phospholipids. The role of electrostatic interactions in the initial 
formation of the Cyt c-membrane complex was investigated by florescence spectroscopy, ion mobility 
mass spectrometry (IMS-MS) and hydrogen-deuterium exchange mass spectrometry (HDX-MS) to 
gain insight into the unique specificity of anionic CL in this pro-apoptotic interaction. 
 
2.2 Experimental Methods 
2.2.1 Reagents and Supplies 
Cytochrome c (Cyt c) from equine heart (≥99%), deuterium oxide (D2O − 99.99%), 
acetic acid (99.7%), and pepsin from porcine mucosa were purchased from Sigma Aldrich (St. 
Louis, MO). NHS-activated agarose beads were purchased from Fisher Scientific (Mississauga, 
ON). 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dihexanoyl-sn-glycero-3-
phosphocholine (DHPC) and Cardiolipin (ammonium salt) lipids were purchased from Avanti 
Polar Lipids Inc. (Alabaster, AL). Solutions were prepared with HPLC water (Fisher Scientific), 
excluding lipid stocks which were prepared in ethanol (≥ 99%) and frozen at ≤ -20°C.  
2.2.2 Fluorescence Spectroscopy  
Intrinsic fluorescence of Cyt c in the presence of phospholipids was probed using a 
BioTek Synergy H4 Hybrid Reader. Florescence measurements were obtained under conditions 
analogous to those used for global and local TRESI-HDX (1:10 protein:lipid ratio, 10% EtOH 
(v/v) in H2O, pH 7). Emission spectra were acquired with an excitation wavelength of 280 nm 
over 300-400 nm (bandwidth = 9.0 nm, read height = 8 nm). For titration experiments, protein-
lipid preparations were analyzed in triplicate at protein-to-lipid ratios of 1:1, 1:2, 1:4 and 1:10. 
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Spectroscopy measurements were acquired at 22°C ± 0.5°C with buffer only, lipid only and 
protein only controls at each concentration tested. 
 
2.2.3 Protease Preparation 
Pepsin from porcine mucosa and NHS-activated agarose beads (2:5 w/w) were 
resuspended in coupling buffer (0.1 M sodium phosphate, 0.15 M NaCl, pH 4) and rotated for 17 
hours at 4°C. The unbound protease was aspirated, and beads resuspended in blocking buffer 
(1 M Tris–HCl, pH 4) then rotated at room temperature for 1 hour. The beads were washed five 
times with 10% acetic acid (v/v) via centrifugation at 1000 x g for 2 minutes and stored at 4°C. 
 
2.2.4 Microfluidic Device Fabrication 
The microfluidic device used for time-resolved ESI (TRESI) measurements was built as 
previously described.130 Briefly, a VersaLaser™ was used to etch a proteolytic chamber into a 
poly(methyl methacrylate) (PMMA) surface measuring 5.1 cm × 2.0 cm × 1.2 cm.  A rapid-mixing 
device was made by inserting an inner glass capillary (outer diameter of 151.0 μm) inside a 28-gauge 
metal capillary (inner diameter of 178.8 μm), creating an intercapillary space of 27.8 μm. The end of 
the glass capillary was sealed using the VersaLaser, and a notch cut 2 mm from the sealed end.  
Hydrogen deuterium exchange (HDX) labelling reactions were carried out in the volume between the 
inner and outer capillaries. For global measurements, the outer capillary was connected directly to the 
heated electrospray source; whereas, for localized measurements, the TRESI mixer was connected to 
an acid channel through a valco t-mixer followed by on-chip proteolytic digestion (Figure 2.3). 
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Figure 2.3. Schematic representation of the capillary-based mixer used for TRESI-HDX-
MS. Protein-lipid solution in an inner glass capillary flow through a notch cut 2 mm from the 
sealed end and mixes with deuterium flowing in the outer metal capillary. The deuterium 
labelling reaction is quenched by lowering the pH with acid followed by online digestion by 
immobilized pepsin beads on a poly (methyl methacrylate) (PMMA) platform. Peptides are 
introduced into the mass spectrometer by electrospray ionization. For global measurements, 
labelled protein was infused directly into the mass spectrometer without acidification or protease 
digestion. Deuterium incorporation is measured by a delta (Δ) mass shift on the mass spectrum, 
enabling characterization of structural changes from transient protein-lipid interactions. 
 
2.2.5 Global HDX 
50 μM Cyt c only or Cyt c-phospholipid solution in a 1:10 protein:lipid ratio were infused into 
an inner glass capillary at 2 μL/min, and mixed with D2O in the outer metal capillary at a flow rate of 
8 μL/min. The reaction volume in the mixing chamber was increased by adjusting the position of the 
inner capillary relative to the outer capillary, thereby increasing the labelling time before direct 
introduction to a Synapt G1 Q-TOF MS. The instrument was operated at a source voltage of 3500 V 
 32 
 
in positive ion mode, and samples scanned over a range of 400–4000 m/z. Time-dependent deuterium 
incorporation was monitored at reaction times from 0.28 to 2 seconds by withdrawing the inner 
capillary from the end of the outer capillary in 1 mm increments (total flow rate of 10 μL/min). The 
amount of deuterium incorporated into the protein (backbone amide and sidechains) was calculated 
from the difference between the theoretical and observed (deuterium labelled) molecular masses for 
Cyt c, measured as a delta (Δ) m/z, for the protein only and in the presence of DMPC or CL 
phospholipids. A background polysiloxane at 445.12003 m/z was used as an internal lock mass in the 
mass shift calculations (Δ m/z x z = Δ Da). HDX uptake results were averaged for the 6+, 7+ and 8+ 
charge states across triplicate acquisitions at each timepoint.  
 
2.2.6. Ion Mobility Spectrometry 
Traveling-wave ion mobility (IMS-MS) experiments were performed on a Waters Synapt G1 
Q-TOF instrument using electrospray ionization (ESI). Nitrogen gas was used for both the source and 
ion mobility T-wave cell, whereas argon gas was used in the trap region of the mass spectrometer. The 
instrument was operated in positive ion mode with a capillary voltage of 3000 V, sampling cone of   
30 V, source temperature of 80 °C and cone gas flow of 25 L h−1. IMS-MS measurements were 
carried out in triplicate on Cyt c only and in a 1:10 ratio with CL or DMPC phospholipids. Protein-
lipid solutions were infused at rate of 5 μL/min and mass spectra were acquired for 5 minutes over a 
mass range of 400–4000 m/z. Optimal IMS separation was obtained using 350 ms−1 IMS wave 
velocity and 11 V IMS wave height, with trap and transfer energies set to 10 V. Transfer T-wave 
velocity of was held at 180 ms−1 with a wave height of 8 V.  IMS-MS results were analysed using 
MassLynx version 4.1 (Waters). 
 33 
 
2.2.7. Local TRESI-HDX Measurements 
Local hydrogen-deuterium exchange measurements (HDX) were performed using a 
microfluidic TRESI device as depicted in Figure 2.2. Sample solutions were prepared with 50 μM Cyt 
c only or Cyt c pre-incubated with CL, DMPC or DHPC in a 1:10 protein-to-lipid mixture. Cyt c-lipid 
solutions were infused into the inner capillary at 2 μL/min and mixed with 2 μL/min D2O in the outer 
metal capillary. The HDX reaction was quenched by the introduction of 10% acetic acid at 12 μL/min 
of (pH 2.5) followed by online digestion with pepsin. Labelled peptides were sprayed directly into a 
Waters Synapt G1 Q-TOF instrument operated in positive ion mode with a source voltage of 3000 V. 
and mass range of 400-1500 m/z. 
 
2.2.8. Data Analysis 
Peptides were identified using the FindPept tool on the ExPASy Proteomics server.131 and 
sequences confirmed via MS/MS with analysis in mMass.132 Deuterium uptake per peptide was 
calculated using Mass Spec Studio133 by matching experimental deuterium uptake to the theoretical 
isotopic distribution for the native peptide sequences. Changes in deuterium uptake for ‘protein & 
lipid’ versus ‘protein only’ states were summed across 3 timepoints (labelling times of 0.5, 1 and 2 
seconds) and averaged across technical triplicates from two different preparations (n=6 replicates in 
total). Changes in deuterium uptake were considered significant if they exceeded two times the 
standard deviation (2σ), with propagation of error from the ‘protein & lipid’ versus ‘protein only’ % 
D2O uptake measurements. Protein structures were rendered using PyMol v1.5.0.4 (Schrödinger, LL) 
and mapped onto the protein crystal structure for equine Cyt c (pdb: 1hrc). 
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2.3 Results & Discussion 
The binding of cationic phosphatidylcholine (PC) and anionic cardiolipin (CL) to Cyt c was 
probed by monitoring instrinsic fluorescence in the presence of phospholipids. Due to the close 
proximity of Cyt c’s heme moeity to the lone tryptophan residue (Trp59), changes in the emission 
spectrum could be attributed solely to the alterations in the enviroment of tyrosine residues upon 
phospholipid binding. Following excitation at 280 nm, the emission spectra for Cyt c showed an apex 
peak at 303 nm, consistent with the the instrinsic fluorescence characteristics of tyrosine.134 In the 
presence of both PC and CL phospholipids, the intensity of instrinsic fluorescence decreased upon 
establishment of  protein-lipid interactions, resulting in quenching of fluorescence signal (Figure 2.4).  
 
 
Figure 2.4. Fluorescence spectra for Cyt c with CL, DMPC and DHPC phospholipids. Apex 
signal from tyrosine residues (303 nm) in Cyt c quenched upon binding to phospholipids.   
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Though fluorescence spectroscopy lacks the resolution to distinguish between tyrosine 
residues in the Cyt c  sequence (Tyr48, Tyr67 and Tyr97), the magnitude of the quenching effect was 
observed to increase as a function of the protein to-lipid ratio (Figures 2.5-2.7). Comparing decreases 
in fluorescence intensity at 1:1, 1:2, 1:4 and 1:10 protein-lipid ratios, negatively charged CL showed 
the greatest magnitude of fluorescence quenching relative to Cyt c alone (Figure 2.5). Based on the 
relative magnitudes of the tyrosine fluorescence response, it can be infered that CL has a stronger 
affinity for Cyt c than positively charged DMPC and DHPC. This is consistent with what would be 
expected for an electrostatically-driven interaction. 
 
Figure 2.5. Fluorescence spectra for Cyt c at increasing concentrations of CL lipids. Apex 
signal from tyrosine residues (303 nm) decreased as a function of increasing CL concentration, 
demonstrate proof of Cyt c-CL interaction. 
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Differing only in acyl chain length, positively charged DMPC and DHPC showed similar 
extents of florescence quenching at 1:10 protein-to-lipid ratios (Figures 2.4). At a 1:1 protein-to-lipid 
ratio, Cyt c with DMPC did not show any significant quenching relative to Cyt c only. Additionally, 
no significant difference was noted between the 1:2 and 1:4 Cyt c-to-DMPC ratios (Figure 2.6). In 
contrast, the signal for Cyt c with DHPC decreased at just a 1:1 ratio. The fluorescence quenching 
effect  increased sequentially as a function of protein-to-lipid ratio up to the 1:10 ratio used for IMS-
MS and TRESI-HDX (Figure 2.7). 
 
 
 
 
Figure 2.6. Fluorescence spectra for Cyt c at increasing concentrations of DMPC 
phospholipids. Apex signal from tyrosine residues (303 nm) decreased sequentially using 1:2, 
1:4 and 1:10 protein-to-DMPC ratios. 
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Figure 2.7. Fluorescence spectra for Cyt c at increasing concentrations DHPC 
phospholipids. Apex signal from tyrosine residues (303 nm) decreased as a function of 
quenching from binding to DHPC phospholipids. 
 
The lipid only controls (Figure 2.8) showed no significant difference in intrinsic fluorescence 
at concentrations used in the titration analysis. Peak fluorescence signal in the lipid only controls was 
noted to overlap the tyrosine emission spectra observed for Cyt c in the presence of phospholipids 
(Figure 2.4-2.7). The intensity of fluorescence response in the absence of protein can be attributed to 
light scattering as previously described for phospholipid-based model membrane systems.135,136 
Common strategies for mitigating light scattering in studies of membrane proteins include measuring 
typothophan emission at 350 nm instead of  tyrosine fluorescence at 303 nm, and the use of additives 
to increase the refractive index.137 For the Cyt c-lipid system, the presence of the heme moeity 
quenched fluorescence at 350 nm precluding analysis of trypothophan fluorescence upon lipid 
binding. The presence of heme protein also increased the refractive index of the system enabling a 
relative assessment of Cyt c-lipid interactions by tyrosine fluorescence quenching (Figure 2.4). 
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Figure 2.8. Fluorescence spectra for lipid only controls at concentrations used in titration 
analysis. Error bars reflect standard deviation in measured fluorescence from triplicate 
preparations. No significant difference in intrinsic fluorescence at increasing concentrations of 
CL, DHPC or DMPC lipids alone. 
 
To investigate class-dependent differences in Cyt c-lipid binding highlighted by fluorescence 
spectroscopy, global time-resolved hydrogen-deuterium exchange (TRESI-HDX) measurements were 
performed on Cyt c pre-incubated with anionic cardiolipin (CL) or cationic phosphatidylcholine (PC) 
at a 1:10 protein:lipid ratio. The “time-resolved” aspect of the approach facilitates characterization of 
transient structural changes using millisecond-to-second D2O exposure times in contrast to 
conventional HDX workflows carried out on a minutes to hours timescale.38,138,139  
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Using a capillary-based TRESI mixer, time-dependent deuterium incorporation was monitored from 
0.28 to 2 seconds, with the hydrogen exchange rate dependent primarily on hydrogen bonding (i.e. 
secondary structure) and the degree of solvent exposure, as influenced by electrostatic interactions 
with phospholipids.35,37 Globally, Cyt c was observed to take up more deuterium in the presence of 
DMPC, indicative of increased dynamics relative to the protein alone. In contrast, Cyt c showed a 
persistent decrease in deuterium incorporation in the presence of CL suggesting a more compact 
protein conformation upon CL binding (Figure 2.9).  
 
 
Figure 2.9. Global HDX results for Cyt c in the presence of CL and DMPC phospholipids. 
Results represent average deuterium incorporation from 6+, 7+ and 8+ charge states over labelling 
times from 0.28 to 2 seconds fitted as an exponential rise to maximum, f=a*(1-exp(-b*x)). Error bars 
represent ± standard deviation from n=3 replicates. See Appendix 1 for curve fitting analysis from 
Global HDX results. 
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Ion mobility spectrometry-MS (IMS-MS) was used to provide further insight into the 
conformational heterogeneity in the lipid-bound Cyt c ensemble as previously suggested by time-
resolved florescence (FRET) experiments.125,126 As a gas-phase analogue of gel electrophoresis, ion 
mobility separates ions based on their size, shape and charge as they traverse the ion mobility cell. 
Shorter drift times are indicative of a faster mobility and more compact gas-phase protein structure, 
whereas longer relative mobility times corresponded to more extended protein conformations.47,140 
For Cyt c only (pH 7), the observed drift time chromatogram showed a predominant 7+ charge state 
with a Gaussian distribution centered at 6.55 ms  ±  0.06 ms (Figure 4). This is consistent with 
previous IMS and native MS studies of Cyt c.141,46,142,143  
The addition of phospholipids resulted in the formation of two newly dominant sub-
populations, one with increased mobility and an apex drift time of 7.05 ms ± 0.07 ms, and a second 
peak with decreased mobility at 6.04 ms ± 0.11 ms (Figure 4). Though both sub-populations are seen 
with the addition of CL or DMPC, the more compact conformation with decreased mobility was 
observed to be more heavily populated in the presence of CL. This agrees with a negative drift time 
differential of - 0.51 ms for ‘Cyt c & CL’ – ‘Cyt c only’ considering the apex of the corresponding 
peaks in the drift time chromatogram (Figure 2.10). The more extended conformation with increased 
mobility was dominant in the presence of DMPC, corresponding to a positive drift time differential of 
1.01 ms for ‘Cyt c  & DMPC’ – ‘Cyt c only’ (Figure 2.10) These IMS results agree with the global 
HDX results showing a more extended protein conformation with positively charged DMPC, and 
more compact structure with negatively charged CL (Figure 2.9).  
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Evidence for differential conformer populations between lipid classes is further supported by 
the charge state distribution observed through native mass spectrometry (MS). Consistent with 
previous MS characterization of native Cyt c,143,144 the protein only spectra was predominantly 
comprised of the 7+ charge state. Incubation with negatively charged CL promoted the formation of 
lower charge states (6+ and 7+) during the electrospray ionization process. In contrast, Cyt c in 
presence of DMPC showed an increased proportion of the 8+ charge state (Figure 2.10), in line with 
of a more extended protein structure during the solution to gas-phase transition.  
 
Figure 2.10. Ion mobility drift time chromatograms for Cyt c only and with CL or DMPC 
phospholipids. Cyt c with CL exhibited a shift in population towards a more compact protein 
conformation (decreased drift time) relative to Cyt c only. Cyt c with DMPC showed a more ended 
conformation with a longer drift time. Native MS spectra of Cyt c show differential charge state 
distributions consistent with the conformational heterogeneity observed by Global HDX and IMS-
MS. 
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Following protease digestion by pepsin and MS/MS analysis, 99% sequence coverage was 
obtained for Cyt c including heme contact sites (Cys14, Cys17, His18, Met80), and residues 
implicated in the extended lipid anchorage model (Asn52, Lys72, and Lys73). Overall, the local 
measurements probed by TRESI-HDX agree with the differences observed in Global HDX 
analysis of the intact protein. CL-bound Cyt c showed decreased levels of deuterium uptake in 
peptides spanning covalent thioester linkages (Cys14 & Cys17) and axial ligands (His18 & 
Met80), reflecting a more compact Cyt c conformation relative to non-lipid bound Cyt c. This is 
consistent with previous solid-state NMR and FTIR measurements of Cyt c bound to membrane 
conformers with preservation of secondary structure upon peripheral interaction with the 
membrane interfaces.111 Interestingly, CL did not induce any significant decreases in deuterium 
uptake in the region spanning the C-site (including Asn52) previously implicated in the formation 
of hydrophobic interactions and/or hydrogen bonding.122,124 In regards to the electrostatic 
interactions proposed by the lipid anchorage model,122,123 the TRESI-HDX results showed 
decreased uptake consistent with prior identification of the A-site (Lys72/73) as a lipid-binding 
region. However, decreased deuterium uptake around Lys72/73 was observed with both positively-
charged (PC) and negatively-charged (CL) phospholipids. This suggests that the interactions at 
this proposed (A-site) for lipid-binding may not be solely driven by electrostatic forces. 
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Figure 2.11. TRESI-HDX measurements comparing Cyt c with CL, DMPC or DHPC 
phospholipids.  Differences between ‘protein & lipid’ versus protein only summed across 
labelling times of 0.5, 1 and 2 seconds. For graphs, positive (red) bars indicate increased uptake 
in the presence of phospholipids whereas negative (blue) bars indicate decreased deuterium 
uptake relative to protein only. 95% confidence intervals (2σ) depicted in grey (dashed lines) for 
differences observed in each peptide across n=6 measurements. Peptides exhibiting differences 
below the 2σ significance threshold are denoted in grey. Using the same colour scheme, results 
were mapped onto the protein crystal structure for equine Cyt c (pdb: 1hrc). 
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With DMPC and DHPC, Cyt c showed increased uptake in peptides spanning the N-
terminus and heme contact residues (Cys14/Cys17/His18) located in the proximal face of the heme 
pocket. Comparing differences in uptake values between the positively charged PC phospholipids, 
it was noted that at the same Cyt c:lipid molar ratio (1:10), DMPC induced less significant 
differences in deuterium uptake relative the shorter PC lipid, DHPC. Given that acyl chain length 
is the only structural difference between DMPC and DHPC, this is likely indicative of different 
affinities, as previously shown with fluorescence spectroscopy under the same experimental 
conditions (Figure 2.6-2.7).  
 
Figure 2.12: Proposed electrostatic priming effect for Cyt c with PC and CL phospholipids.  
TRESI-HDX results for DHPC and CL centered on heme contact residues. Peptides coloured in 
blue represent a significant decrease in uptake relative to Cyt c only, whereas those in red 
represent a significant increase in uptake. Based on HDX results, electrostatic interactions with 
negative charged CL promote a tightening in Cyt c whereas PC lipids increase dynamics on the 
proximal face of the heme binding pocket containing Cys14 and Cys17. 
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From a mechanistic perspective, peroxidases typically contain a penta-coordinated heme 
group with a vacant (distal) site where H2O2 can bind and initiate the catalytic cycle.145 Native 
Cyt c is paradoxical in that it is hexa-coordinated with His18 and Met80 axial ligands and four 
pyrole nitrogens, yet still exhibits peroxidase activity. It has been proposed that interaction with 
phospholipid bilayers induce a change in Cyt c conformation to a penta-coordinated heme state 
that is capable of CL peroxidation.146–148 Cyt c first associates with the membrane then gains 
peroxidase active as a result of H2O2-induced covalent modifications. Recent experimental evidence 
has shown oxidation at Tyr67 or Met80, 149,150 and side chain carbonylation at Lys72/73151  to be pre-
requisite modifications for Cyt c peroxidase activity. This  two-stage activation  model is also further 
corroborated by the well-established initial lag phase in Cyt c-CL  peroxidase kinetics.149 
Interestingly, the peptide regions implicated in modification-driven activation of 
peroxidase activity (Tyr67, Lys72/Lys73, Met80) showed decreased uptake upon binding to 
phospholipids. Though observed with both PC and CL lipids, the peptide spanning the Met80-
heme bond (77-91) showed the largest decrease in the presence of CL. This decrease in dynamics 
in the region spanning Met80-heme ligation may facilitate activation by making H2O2-induced 
modification of Cyt c more energetically favourable as intracellular H2O2 levels rise from 
submicromolar to submillimolar in the early stages of apoptosis.56,57 In contrast, cationic DMPC 
and DHPC destabilize heme contacts that are structurally needed to form a penta-coordinated 
conformation of Cyt c. Thus, conformational priming from interactions with PC lipids likely makes 
peroxidase catalysis less energetically favourable by preventing binding of H2O2 and/or 
stabilization of the oxidase heme (Fe=O) intermediate (Figure 2.13).  
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Figure 2.13. Proposed reaction coordinate diagram based on conformational dynamics 
from electrostatic interactions with PC and CL phospholipids. CL primes native, hexa-
coordinated, Cyt c, facilitating interactions required to modify Cyt C into peroxidase-active state. 
PC lipids induce partial unfolding of heme binding pocket preventing stabilization of the oxidase 
heme (Fe=O) intermediate for peroxidase catalysis. 
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2.4 Conclusion 
Taken together, TRESI-HDX analysis of Cyt c with PC and CL lipids demonstrates that 
electrostatic contributions of different lipid classes should be considered when designing 
experiments using model membrane surfaces. In probing exclusively for electrostatic interactions, 
the results support a two-stage model in which lipids prime Cyt c peroxidase activation by 
influencing conformational dynamics in the establishment of the Cyt c-membrane assembly. 
Global HDX, IMS-MS and TRESI-HDX analyses are in agreement, with PC lipids causing unfolding 
of one face of the heme pocket, impacting Cyt c’s ability adopt the penta-coordination heme 
conformation that is a prerequisite for peroxidase activity. Cyt c was also observed to adopt a more 
compact protein conformation when bound to CL, with no evidence of global unfolding by HDX or 
IMS-MS. This compact CL-bound Cyt c structure may facilitate further activation of peroxidase activity 
in Cyt c as required for mitochondrial-induced apoptosis. Collectively, this work demonstrates TRESI-
HDX as a powerful tool for investigating conformational dynamics in lipid binding with adequate 
sensitivity for probing transient changes at protein-membrane interfaces. 
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Chapter 3 – Optimization of proteomic methods for studying complex 
biological samples from Bordetella Pertussis 
 
3.1 – Introduction 
While studies of biochemical processes such as the pro-apoptotic Cyt c pathway 
described in the previous chapter provide value at a mechanistic level, it is important to 
understand that these types of interactions do not occur in isolation. Greater understanding of 
complex cellular networks requires larger scale analyses of proteins and their functions. 
Fortunately, 20 years of development has made holistic profiling routinely accessible via LC-
MS-enabled shotgun proteomics. 
 
3.1.1 Proteomics in Vaccine Development 
Applications of shotgun proteomics techniques have led to tremendous advances in our 
understanding of human diseases. However, substantial gaps still remain in medically-relevant 
proteomes including many microbes responsible for infectious diseases. While the success of 
genome projects has provided us with vast information on the genes of many pathogenic species, 
development of  new vaccines depends on identification and characterization of potential 
antigens for eliciting a protective immune response.152 Historically, the role of MS has been 
limited to the confirming the identity protein antigens in recombinant and viral vaccines. In 
addition to intact mass analysis typically used for identity, LC-MS can also provide information 
on primary amino acid sequence, disulfide bonds, and post-translational modifications (PTMs) 
such as glycosylation.153  
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Another area of biopharmaceuticals where MS is increasingly being applied is the 
profiling of host cell protein (HCP) impurities which are expressed during large-scale cultivation 
of biologics.154 Monitoring the composition and abundance of HCPs across different stages of a 
manufacturing is a fundamental aspect of process development and control. Historically, HCPs 
have been detected using Enzyme-linked immunosorbent assays (ELISA).155 While commonly 
accepted by industry and health authorities for determining relative HCP amounts (usually 
expressed in ppm levels relative to the main protein therapeutic), polyclonal multi-analyte 
ELISAs offer minimal information on the identity of individual proteins within a population of 
HCPs.155 Moreover, they are often subject to matrix effects when trying to compare across 
different manufacturing stages. Consequently, there is increased interest in MS-based proteomics 
as an orthogonal approach for detecting proteins in biopharmaceuticals.156 
The coming sections in this chapter will describe applications of shotgun proteomics for 
the characterization of acellular component Pertussis vaccines manufactured by Sanofi Pasteur 
Canada. Chapter 4 will highlight development of a targeted proteomics method for absolute 
quantitation of specific residual toxins from Bordetella pertussis (B. pertussis). 
 
 
 
 
 
 
 
 
 50 
 
3.1.2 Bordetella Pertussis Pathogenesis 
Pertussis, also known as whooping cough, is a highly contagious respiratory disease 
caused by infection of an aerobic, gram-negative bacterium called Bordetella pertussis (B. 
pertussis). Molecular pathogenesis of B. pertussis is driven by virulence factors which can be 
categorized as adhesions or toxins based on their mechanism of action. Adhesions, such as 
filamentous hemagglutinin (FHA), pertactin (PRN) and fimbriae of serotype 2 or 3 (Fim 2/3) are 
cell-surface proteins which serve as attachment points for B. pertussis to epithelial tissue in the 
respiratory tract (Figure 3.1). Once anchored, B. pertussis makes use of pertussis toxin (PT), 
tracheal cytotoxin (TCT), adenylate cyclase toxin (ACT), and dermonecrotic toxin (DNT) to 
downregulate cellular and antibody-mediated immune responses.  
Pertussis infections were widespread until the late 1940s, with annual case rates as high 
as 270 000 in the United States and fatality rates at about 10%.157 Whole cell vaccines (wP), 
comprised of inactivated B. pertussis bacteria were introduced in the late 1940s and were hugely 
successful in reducing incidence rates throughout the 1950s and 1960s in areas with high vaccine 
coverage.157 Adverse publicity in the 1970s led to decreased compliance and prompted the 
development of acellular Pertussis (aP) vaccines with proteins components purified from 
B.pertussis bacteria.158 To date, up to five proteins have been harnessed for their immunogenic 
properties as components in acellular vaccines: detoxified PT, cell surface adhesion proteins 
(FHA & PRN), and pili-forming agglutinogens (FIM 2 & 3). Since the transition to aP vaccines 
in the 1990s, case rates and regional pertussis epidemics have increased steadily.159 This has 
sparked renewed interest in understanding molecular mechanisms of B. pertussis pathogenesis 
with the goal of developing a new generation of safe and effective Pertussis vaccines.160 
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Figure 3.1. Bordetella pertussis organism with virulence factors for pathogenesis. Pertactin, 
Pertussis toxin, Filamentous Hemagglutinin, Fimbriae type 2 & 3 harnessed as antigen 
components in acellular whooping cough vaccines. Adenylate cycle toxin (ACT), 
dermoneucrotic toxin (DNT), and tracheal cytotoxin (TCT) are monitored as residual host cell 
impurities during downstream purification from fermenter harvest. Image source: Sanofi Pasteur 
Canada. Accessed on March 6, 2019 through public webpage: 
http://www.museumofhealthcare.ca/explore/exhibits/vaccinations/pertussis.html. 
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Advancements in shotgun proteomics have coincided with increased interest in applying 
LC-MS for protein identification in biopharmaceutical development.84 Nevertheless, there 
remains a need for sample processing methods that are unbiased to protein solubility and can 
provide a greater depth of coverage from proteomic analyses. One such method is filter-aided 
sample preparation (FASP) first introduced by the Mattias Mann group in 2009161 and adapted 
into a “suspension trap” (S-trap) format in 2014.162 In contrast to a traditional in-solution 
digestion performed via sequential aqueous reactions in a test tube, S-trap enzymatically digests 
proteins in a spin column format.163 The top layer contains porous silica filter media to trap 
particulate protein suspensions and the bottom layer holds C18 resin for online clean-up of 
digested peptides.163 Advantages of spin column format include the ability to pre-concentrate 
samples and increases enzymatic digestion efficiency due to the physical space constraints within 
the pores of the column. Additionally, the ability to efficiently clean-up samples during sample 
loading enables the use of detergents such Sodium Dodecyl Sulfate (SDS) which was previously 
been limited due the incompatibility of detergents with MS analysis.  
This section describes shotgun proteomics analyses performed on unpurified culture 
supernatant with the aim of increasing the depth of protein detection from the secretome of B. 
pertussis.164 An evaluation of digestion protocols was then performed to assess whether the S-
trap protocol could enhance HCP detection, and improve sequence coverage for hydrophobic 
antigens such as pili-forming FIM 2/3. 
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3.2 Experimental Methods 
The sample digestion protocols are described based on total protein from Bradford 
analysis. In-solution and S-trap digestion strategies were evaluated to optimize protein detection. 
For both digest protocols, purified FIM antigen was reduced at 95°C for 15 min then sonicated in 
a 40°C water bath for 10 min to further promote solubility. 
3.2.1 In-Solution Sample Digestion 
150 µg of culture supernatant or 25 µg of purified FIM antigen containing both serotype 
2 or 3 (Fim 2/3) were digested in triplicate using an in-solution digestion protocol. Briefly, 1 M 
ammonium bicarbonate (ABC) and 1% of acid-labile surfactant (Rapigest)165 were added to 
samples to a final concentration of 0.1 M ABC and 0.1% Rapigest considering a 150 µL digest 
volume. Samples were incubated at 60°C for 30 min to facilitate disulfide bond reduction with 
10 mM of Tris(2-carboxyethyl) phosphine hydrochloride(TCEP). Iodoacetamide (IAA) was then 
added (final concentration 20mM) for alkylation of the reduced cysteines. Following incubation 
for 60 min at room temperature, the reduced and alkylated samples were enzymatically digested 
using a Trypsin/Lys-C proteolytic enzyme mixture at an enzyme-to-substrate ratio of 1:20 (w/w) 
for 4 hr at 37°C. Digests were quenched by the addition of 4 μL of TFA and confirmed to have a 
pH of ~2 using a pH strip. The acidified digest samples were then incubated at 37°C for 30 min 
and centrifuged at 8,100 x g for 10 minutes to facilitate Rapigest hydrolysis.  
3.2.2 S-Trap Sample Digestion 
A suspension-trap (S-trap) digestion was performed as per the vendor’s recommended 
protocol 162,163 with 25 µg of culture supernatant or purified FIM antigen samples. Briefly, the 
protein samples were mixed 1:1 (v/v) with 10 % SDS, 100 mM triethylammonium bicarbonate 
(TEAB, pH 7.55) then reduced and alkylated as described above for the in-solution digestion. 
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12.5 % aqueous phosphoric was added to a final concentration of 1.2 %. 6 volumes of S-Trap 
protein binding buffer (90% MeOH, 100 mM TEAB, pH 7.1) was then added to form colloidal 
protein particulate. The acidified SDS lysate/protein mixtures were loaded onto S-trap micro 
columns via centrifugation at 4000 x g for 2 minutes, effectively trapping the protein within the 
silica matrix of the spin column. Captured protein was washed by spinning through 3 volumes 
(150 µL) of S-Trap binding buffer. 25 µL of digestion buffer containing Trypsin/Lys C at 1:10 or 
1:20 protease-to-substrate ratio (w/w) was added to the top of the column and incubated for 1 hr 
at 47°C (Figure 3.2). Digestions were performed in duplicate for each sample type tested. 
Peptides were eluted from the spin column by centrifugation at 4000 x g for 2 minutes with 40 
μL of TEAB; 40 μL of 0.1% FA; and 35 µL of 50% ACN, 0.1% FA. Fractions were pooled and 
frozen at -80°C. Prior to LC-MS analysis, samples were diluted 3-fold to lower ACN content 
from ~15 to 5% for loading onto the C18 RP-HPLC column.  
 
Figure 3.2. Schematic of a suspension trap (S-trap) sample digestion for LC-MS/MS 
analysis. A protein sample is solubilized with SDS and acidified using phosphoric acid. The 
acidified protein–SDS mixture is added to a methanol-based S-trap binding buffer at pH 7.1 
creating a fine protein suspension that is capture by a silica (SiO2) depth filter.  The sample is 
washed with additional binding buffer whereby proteins are retained, and contaminants are 
removed in the flow through. Trapped proteins are enzymatically digested within the interstitial 
space of the S-trap, “falling” into a lower bed of C18. Peptides are eluted using acetonitrile 
followed by an optional concentration step prior to LC-MS/MS analysis. 
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3.2.3 Data Acquisition 
Shotgun protomics analyses were performed on 425 ng culture supernant and 0.5-1 pmol 
of purified FIM digest samples using a UltiMate 3000 RSLCnano UHPLC system (Thermo 
Scientific) plumbbed in a “trap-elute” configuration (Figure 3.3). Pre-concentration and desalting 
were performed online using a C18 trap column (5mm x 300 µm i.d.) followed by seperation on 
an analytical column (PepMap100 C18 75 µm x 15cm 3µm). Loading pump mobile phases 
consisted of water (mobile phase A) and acetonitrile (ACN; mobile phase B) with 0.1% TFA. 
Nano pump mobile phases were mixed with FA as an  ion-pairing agent during elution and MS 
analysis.  nanoLC experiments were run at a flow rate of 300 nL/min with the trap column set at 
40°C and the analytical column held at 30°C. 95 min and 45 min analytical gradients (1% to 
35% B) were used for the cultutre supernant and FIM digest samples, respectively.  
 
Figure 3.3. Trap-elute nanoLC setup for LC-MS/MS experiments. Online pre-concentration 
and desalting was performed using the loading pumps at 5 µL/min. Peptides were eluted by the 
nano pumps at 300 nL/min onto a EasySpray analytical column with integrated ESI emitter.  
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Shotgun MS acqusitions were performed on a Q Exactive HF mass spectrometer (Thermo 
Scientific) with a survey scan from 400-2000 m/z and up to 10 dependent MS/MS scans. The 
survey scan was acquired at 120, 000 resolution with an Automatic Gain Control (AGC) target of 
3e6 and maximum injection time (maxIT) of 200 ms. Data dependent MS/MS scans were 
acquired at 60, 000 resolution with an AGC target of 3e6 and maxIT of 200 ms. Precursors were 
selected using a quadrupole isolation window of 1.6 m/z and fragmented by HCD using 
normalized collision energy of 27. Dynamic exlusion was applied for 12 seconds. Instrument 
tune parameters of note: capillary voltage of 1.9 kV, capillary temperature of 275°C and S lens 
RF voltage set to 50.0. 
 
Figure 3.4. Schematic of a shotgun proteomics workflow for identification of proteins from 
Bordetella pertussis. nanoLC-MS/MS workflow for bottom-up proteomic analysis consist of a 
sample preparation in which proteins are extracted, solubilized and denatured with surfactact to 
facilitation proteolytic digestion. Peptides are then seperated by nano Ultra-Performance Liquid 
Chromatography (UPLC) and detected by data-dependentacqusition (DDA).  Adapted from 
James et al. 2018.166  
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3.2.4 Data Processing for Shotgun Protein Identification 
 NanoLC-MS/MS results files were imported into Proteome Discoverer version 2.1 
(Thermo Scientific) for data processing. Databases containing the following protein sequences 
were used for all analyses: SP antigens (67 sequences), B.pertussis proteome Tohama I strain 
(3529 sequences), and common contaminants (118 sequences).167 Experiments were searched 
using the Sequest HT algorithm with trypsin as the enzyme. A maximum of 4 missed cleavages 
were considered with the following dynamic modifications: carbamidomethyl (C), deamidation 
(NQ), oxidation (M) and carbamylation (K). Precursor mass tolerance was set to 10 ppm and the 
fragment mass tolerance to 0.02 Da. Results were filtered based on a target decoy search with a 
false discovery rate of 1% at the peptide-spectral match (PSM) level. 
 
3.3 Results & Discussion 
 Visual inspection of total ion chromatograms (TICs) from the in-solution and S-trap 
digests revealed significant “clean up” effects from the S-trap digestion protocol. Comparing the 
TIC profiles (Figure 3.5), the in-solution digests showed evidence of polymer contamination (80-
85 min) and a late-eluting peak of hydrophobic contaminants (100-105 min) which were not 
present in the S-trap digests from the same starting sample. This represents efficient removal 
matrix components during the wash steps prior to S-trap loading; an option that is not available 
with traditional in-solution digestions. Both samples had approximately the same intensity of 
peptide-related features between 15 and 90 minutes (~2e9) from a comparable 425 ng load on-
column (Figure 3.5). Nevertheless, the S-trap digests (Figure 3.5b) appeared to have more 
defined peaks in the chromatogram and a lower signal-to-noise than the in-solution digest 
samples (Figure 3.5a). 
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Figure 3.5. Comparison of total ion chromatograms for culture supernatant using in-
solution versus S-trap digestion protocols. DDA analysis from 425 ng unpurified culture 
supernatant digested A) in-solution versus B) S-trap with a 1:20 (w/w) enzyme-to-substrate ratio. 
S-trap digestion was noted to remove late eluting salt and polymer contaminants observed in 
samples prepared via in-solution digestion.  
 
DDA search results for unpurified culture supernatant identified 254 proteins belonging 
to 245 protein groups. Of these proteins, 24 were uniquely identified with S-trap digestion versus 
3 proteins unique to the in-solution protocol (Figure 3.6). Comparison of peptide identifications 
showed a similar trend with increased identifications in the S-trap versus in-solution digest 
samples (Figure 3.6). Further comparison of the enzyme-to-protein ratios revealed no significant 
difference in identifications between S-trap digests performed at 1:10 and 1:20 (w/w). The 
results also indicate that a 1:20  ratio was appropriate given the protein load (Figure 3.6). 
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Figure 3.6. Venn diagram comparison of protein and peptide identifications in culture 
supernatant using in-solution versus S-trap digestion protocols. Results represent duplicate 
digestions under the following conditions: S-trap 1:10 (enzyme-to-substrate), S-trap 1:20 and in-
solution 1:20. S-trap digestion performed with a 1:20 enzyme-to substrate ratio was observed to 
maximize the number of peptide and protein identifications.   
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 Given that most antigen components are purified from the culture supernatant prior to 
formulation in the acellular vaccine, one would expect that all the antigen proteins would be 
detectable via DDA of the starting material and would be of relatively high abundance. While 
FHA, PT and PRN were confidently detected amongst the most abundant proteins in the sample, 
coverage of FIM was extremely limited with only one peptide from FIM 2 and no peptides from 
FIM 3 despite the use of acid-labile surfactant to promote solubility.165 Though poor coverage of 
FIM can likely be attributed to its hydrophobicity and propensity for aggregation, its limited 
sequence coverage highlighted a potential gap in the current sample preparation protocol.  
Moving to the S-trap digestion for unpurified culture supernatant improved FIM coverage 
to 2 peptides for FIM 2 and 5 peptides for FIM 3, corresponding to 22 % and 45% sequence 
coverage, respectively. Applying a detection limit of two peptides per protein, the S-trap digest 
protocol enabled detection of a protein that was previously below the detection threshold. Thus, 
implementation of the S-trap technology improved coverage from the in-solution digest profile. 
 As an extension of the improved detection of FIM in the unpurified culture supernatant, 
the S-trap digestion protocol was evaluated for purified FIM antigen as a representative 
hydrophobic, aggregation-prone protein sample. Leveraging biophysical characterization on the 
purified antigen, the temperature during the reduction step was increased from 60 to 95°C to 
promote the disassembly of aggregate fibril structures. To further improve solubility, FIM 
digestion samples were also sonicated for 10 minutes prior to digestion either in ABC buffer 
with 0.1% Rapigest (in-solution digest), or with 5% SDS/100 mM TEAB as per the S-trap 
protocol.  
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  A side-by-side comparison of 500 fmol loaded on-column (Table 3.1) showed a 16-23% 
increase in sequence coverage using S-trap versus in-solution digestion protocols. The TIC traces 
from S-trap FIM digests were noted to have more intense peaks and fewer late-eluting 
contaminants than the in-solution digests, consistent with observations from the unpurified 
culture supernatants. Increasing the on-column load to 1 pmol of in-solution digest was 
necessary to obtain comparable sequence coverage to the S-trap digests for FIM 2 and FIM 3 
(Table 3.1). While there were no HCPs detected with 500 fmol of in-solution digest, 3 HCPs 
were detected using 500 fmol of S-trap and 1 pmol of in-solution digest. The enhanced detection 
of HCPs is in line with increased depth of coverage using the S-trap digestion protocol. 
 
Table 3.1. Sequence coverage results from DDA analysis of purified FIM antigen using S-
trap and in-solution digestion protocols 
Protein 
Amount of protein loaded on-column 
500 fmol 1 pmol 
S-trap In-Solution  In-Solution 
Fim 2  72 % 56 % 71 % 
Fim 3 74 % 51 % 84 % 
 
3.4 Conclusion 
 Shotgun proteomic analyses were successfully performed for the characterization of 
culture supernatant and purified FIM antigen from B. pertussis. Implementation of the S-trap 
digestion protocol improved proteome coverage and enabled confident detection of hydrophobic 
FIM antigen in the unpurified process intermediate. Effective sample cleanup and improved 
sequence coverage were also observed in purified FIM samples. Collectively, these results 
highlight the power of the S-trap technology for hydrophobic proteins and establish proof-of-
concept for further use in vaccine characterization. 
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Chapter 4 – Development of a targeted nanoLC-MS/MS method for absolute quantitation 
of residual toxins from Bordetella pertussis 
 
4.1 – Introduction 
In contrast to recombinant vaccines, acellular Pertussis (aP) vaccines are purified from 
crude fermenter harvest (B. pertussis culture supernatant). Of the virulence factors described in 
Chapter 3, PT is the only toxin that has been selected along with adhesion proteins FHA, PRN 
and FIM as purified components in acellular vaccines.159 Consequently, there is a need to 
monitor for co-purification of other toxins to ensure safety and material consistency.168 Though 
traditionally monitored using enzymatic assays, animal tests, or cell-based approaches such as 
clustering in Chinese hamster ovary (CHO) cells158, the residual toxins from B. pertussis 
represent a unique opportunity to apply the superior specificity and multiplexing capabilities of 
targeted MS to the development of next generation vaccines. In contrast to conventional shotgun 
analysis described in the Chapter 3, targeted MS workflows, such as parallel reaction monitoring 
(PRM), harness the analytical power of MS to target a list of precursors for quantitation, with 
limits of detection in the attamole (atm, 10-18) range on-column.88,91  
4.1.1 –Residual Toxin Background 
Adenylate cyclase toxin (ACT) is 177 kDa immunogenic protein belonging to the Repeats-
in-Toxin (RTX) family of bacterial toxins. Like other toxins in RTX family, ACT contains a C-
terminal glycine rich domain which binds calcium enabling translocation of the N-terminal 
catalytic domain into target cells.169 ACT expression is regulated by the same bvgAS operon as 
other B.pertussis virulence factors, PT, PRN, FHA and FIM.170 Secreted from the bacterial 
cytosol into the extracellular medium, ACT binds to complement receptor 3 (CR3) and integrin 
complex (CD11b/CD18) on the surface of host cells.170,171 Once bound, ACT translocates its 
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catalytic domain to the cytoplasm where it binds calmodulin resulting in conversion of ATP to 
cAMP. Accumulation of intracellular cAMP induces cellular apoptosis and notable toxicity.172,173  
Due to potentially adverse effects, the regulatory limit for ACT is defined as 500 ng per dose of 
aP vaccine as per the European Pharmacopeia (Ph. Eur) 168 and WHO guidance174(Table 4.1). 
Table 4.1 European regulatory limits for residual toxins ACT, DNT and TCT per dose of 
acellular Pertussis vaccine.168  
Toxin 
Molecule 
Type 
Size 
Limit in grams 
per dose 
Limit in moles 
per dose 
ACT Protein 177 kDa 500 ng 2.8 pmol 
DNT Protein 160 kDa Absence N/Ap 
TCT 
Glycopeptide 
(small molecule) 
921 Da 1.84 ng 2.0 pmol 
 Dermonecrotic toxin (DNT) is a 160 kDa protein toxin produced by all bacteria in the 
genus Bordetella. As the name suggests, it’s notable trait is characteristic necrosis of the skin 
when injected into mice intradermally.175 DNT’s role during B. pertussis infection in humans is 
unknown; however, it is noted to lack an export sequence. Therefore, the presence of DNT in 
early stages of manufacturing is likely due to bacterial cell lysis during fermentation.176,177 
 In contrast to ACT and DNT, tracheal cytotoxin (TCT) is a 921 Da glycopeptide released 
from the peptidoglycan layer of the B. pertussis cell wall during logarithmic-phase of bacterial 
growth. Though most gram-negative bacteria recycle this molecule, B.pertussis does so poorly 
instead releasing TCT to the extracellular environment where it binds to ciliated epithelial cells 
in the respiratory tract.178 TCT bears a unique structure which was first reported as GlcNAc1,6-
anhydro-MurNAc-L-Ala-y-D-Glu-meso-diaminopimelic acid -D-Ala (Figure 4.1) by fast-atom 
bombardment (FAB)-MS. Its MurNAc (N-acetylmuramic acid) moiety places it in a family of 
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compounds of bacterial origin known as muramyl peptides.179,180 As per Ph. Eur regulatory 
guidance168, the TCT limit is 2 pmol per dose of aP vaccine (Table 4.1). 
 
Figure 4.1. Structure of TCT, a polymeric peptidoglycan fragment released by Bordetella 
pertussis. Full name: GlcNAc1,6-anhydro-MurNAc-L-Ala-y-D-Glu-meso- diaminopimelic acid 
-D-Ala. Composed of disaccharide glycan moiety N-acetyl glucosaminyl (GlcNAc)-N-
acetylmuramic acid (MurNAc) and a stem of amino acids. Toxicity linked to side-chain 
functional groups and unnatural diaminopimelic acid (Dap) residue.  
 
4.2 – Experimental Methods  
4.2.1 Design of a Targeted MS Method 
Peptide PRM experiments were designed and refined in Skyline version 4.1.181 An in- 
silico tryptic digestion was performed using the fasta sequences for ACT (P0DKX7) and DNT 
(Q7VTS2). Sequences were filtered to be between 8 to 16 residues in length, fully tryptic, and 
lack homology with any other proteins in the B.pertussis proteome. Easily modifiable residues 
(Cys, His, Met) and ragged ends (Arg/Lys repeats) were also avoided.  
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4.2.2 Peptide Standards:  
ACT and DNT sequences identified from the in silico tryptic digestion in Skyline were 
ordered as crude native peptides (SpikeTides™) from JPT Peptide Technologies (GmbH, 
Germany). Selected “top 10” sequences from screening experiments were synthesized using 
JPT’s spot synthesis technology182 as crude heavy peptides with a 15N, 13C labelled terminal 
lysine or arginine (SpikeTides_L™). “Double heavy” absolutely quantified heavy labelled 
proteotypic peptides were custom ordered from JPT Peptides with a 15N, 13C labelled terminal 
Arg or Lys and one other heavy labelled residue per sequence (Spiketides_TQL™, ≥99% 
isotopic purity). Referred to as ‘Qtag peptides’, the Spiktides_TQL™ standards contain a UV-
visible C-terminal tag (Qtag) that is cleaved by trypsin during sample digestion, thereby 
releasing the stable isotope labelled peptide standard for absolute quantitation. Following final 
standard refinement, two peptides per protein were purchased as single heavy (15N, 13C) 
AQUA™ Ultimate peptides (Thermo Fisher Rockford, IL, USA). Starting concentrations were 
determined by amino acid analysis (AAA) for AQUA™ Ultimate peptides (5 pmol/µL, 5% ACN 
in H20) and by UV for the Qtag peptides standards. 
 
 
Figure 4.2. Standard-driven strategy for targeted nanoLC-MS/MS development. Outline of 
iterations performed from  the silico tryptic digests of target proteins (ACT/DNT)  through 
selection of surrogate peptide sequences for absolute quantitation. 
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4.2.3 Sample Preparation: 
Heavy labelled prototypic (Qtag) peptides were resuspended in 1 M ABC 20% ACN and 
pooled into stock solutions containing 375 fmol/µL ACT and 75.0 fmol/µL DNT peptide 
standards, with 3.75 pmol/µL of a carrier peptide for stability. 15 µL of 1 M ABC (pH 7.4-7.5), 
15 µL of 1% Rapigest (v/v), and 10 µL of peptide stock solution were added to 150 µg of culture 
supernatant determined by Bradford assay or 25 µg of purified antigen drug substance 
determined by UV280. Each sample was digested in triplicate. For reduction of cysteines, 3 µL 
of 500 mM TCEP solution was transferred to samples and incubated at 60°C for 30 minutes. For 
alkylation, 3 µL of 1M IAA was then added and vortexed to mix. The samples were incubated in 
a dark drawer for 60 minutes at room temperature. The digest solutions were brought to 150 μL 
total volume with LC-MS water such that the concentration of heavy Qtag standards was 25 
fmol/µL and 5 fmol/µL for ACT and DNT, respectively.   
Sample digestion was carried out at an enzyme-to-substrate ratio of 1:20 (w/w) for 4 
hours at 37°C using a thermomixer incubator set to 300 rpm for mixing. To optimize digestion 
kinetics, a timecourse was also performed at 37 °C with incubation times varied from 1 to 6 
hours. Digests were quenched by the addition of 4 μL of TFA and confirmed to have a pH of ~2 
using a pH strip. The acidified digest samples incubated at 37°C for 30 minutes followed by 10 
minutes of centrifugation at 8,100 x g to facilitate Rapigest hydrolysis. The supernatants were 
transferred to new tubes and stored at -80 °C until LC-MS analysis. Prior to nanoLC-MS/MS 
analysis, digest samples were thawed at room temperature and spiked with AQUA heavy 
peptides to a final concentration of 25 fmol/μL ACT and 5 fmol/μL DNT standards. 
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4.2.3 nanoLC-PRM Data Acquisition 
Targeted parallel reaction monitoring (PRM) experiments were acquired on a  Q Exactive 
HF mass spectrometer with an UltiMate 3000 RSLCnano UHPLC system (Thermo Scientific). 
Chromatographic separation was performed using a trap-elute nanoLC configuration with pre-
concentration using a 5 mm x 300 µm (i.d.) C18 trap column. 1 pmol of purified antigen or 1 µg 
of supernatant digest was loaded onto the trap column via loading pumps run at 5 µL/min After 2 
minutes of on-line desalting, the peptides were eluted onto a PepMap C18 75 µm x 15 cm Easy-
Spray analytical column with integrated ESI emitter. A flow rate of 300 nL/min was used with 
aqueous mobile phase A and organic (ACN) mobile phase B. 0.1% TFA and 0.1% FA were used 
as ion-pairing reagents during the trap and elute phases, respectively. A 95-minute gradient from 
1 to 35% B was used with a total run time of 117 minutes with the column oven (trap) 
temperature was set to 40°C and analytical column set to 30°C. 
 The PRM acquisition method cycled between a Full MS survey scan and up to 15 
MS/MS scans with a 1.4 m/z isolation windows. Data acquisition was scheduled for ±5 minutes 
the observed retention time for each target peptide in a scouting run performed at the beginning 
of the MS acquisition sequence. Survey scans were acquired from 380-2000 m/z with a 
resolution of 120,000, automatic gain control (AGC) of 3 x 106, and maximum injection time 
(maxIT) of 50 ms. MS/MS fragmentation was performed using a normalized collision energy 
(NCE) of 27, maxIT of 300 ms, AGC of 2 x 105, and resolution of 120,000. Instrument tune 
parameters of note: capillary voltage of 1.9 kV, capillary temperature of 275°C and S lens RF 
voltage set to 50.0. 
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Figure 4.3. Schematic of a targeted nanoLC-PRM for absolute quantitation of residual 
toxins from Bordetella pertussis.  LC-MS/MS workflow includes protein extraction, digestion, 
separation by nanoUPLC and scheduled parallel reaction monitoring (PRM) on a Q Exactive HF. 
Method can be applied across manufacturing stages for acellular Pertussis vaccines.  
 
 
PRM results were imported into Skyline (version 4.1)181 for target extracted ion 
chromatogram (XIC) analysis. 3-5 shared transitions were selected per peptide based on 
fragment ion intensity, visual determination of signal-to-noise, and co-elution of native and 
heavy peptide signals. The ratio of native-to-heavy peptide signal was calculated for each peptide 
by summing the integrated peak areas for the selected transitions. Concentrations were 
determined from the native-to-heavy ratio given the known concentration of heavy peptide 
standards spiked into the samples. Mean and standard deviations were calculated from digest 
triplicates acquired individually.  In the optimized PRM method, one peptide sequence per 
protein was used for absolute quantitation and a second for confirmation of protein identity (i.e. 
specificity). 
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4.2.5. Evaluation of linearity, limit of detection, and limit of quantitation 
Applying the optimized PRM method, Spiketides_TQL (Qtag) and AQUA heavy peptide 
standards were used via a spike-in experiment to evaluate the linearity, limit of detection (LOD) 
and lower limit of quantification (LLOQ). Qtag peptides containing two labelled residues 
(double heavy) were spiked into unpurified culture supernatant samples prior to digestion and 
used to normalize for run-to-run variability in absolute MS response. Ultimate AQUA (single 
heavy) peptides were spiked post-digestion with peptide response evaluated from 12.5 amol to 
250 fmol on-column (target loads of 0.0125, 0.025, 0.0375, 0.05, 0.075, 0.100, 0.250, 2.5 and 
250 fmol on-column, respectively). Samples were analyzed in triplicate in unpurified culture 
supernatant. Linear regression analysis was performed in Excel considering the natural logarithm 
of Qtag-normalized areas as a function of AQUA peptide concentration. 
 
 
4.3 Results 
4.3.1 Peptide Screening Results 
In the absence of purified ACT and DNT reference material, a peptide standard-driven 
strategy was employed to identify candidate sequences to serve as surrogate peptides for targeted 
nanoLC-MS/MS analysis. An in silico tryptic digest in Skyline yielded 33 ACT and 32 DNT 
candidate sequences with physiochemical properties conducive to quantitation. These sequences were 
iteratively refined in 3 rounds of optimization experiments (Figure 4.4). First, crude native peptide 
sequences were purchased from JPT peptides and spiked into a purified antigen digest. A Full MS 
PRM method was used to gauge the relative signal intensities of peptide candidates at both the survey 
(MS1) and fragment ion (MS2) levels. Variation in signal intensity between peptides was noted, 
reflecting both differences ionization efficiency and relative ease of synthesis (Figure 4.4a).   
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MS/MS spectra acquired via PRM of the spiked native peptides were searched against the B. 
pertussis proteome using Proteome Discover version 2.1. In all, 31/33 ACT and 25/32 native DNT 
candidates were positively identified, confirming that the MS/MS spectra were of sufficient quality for 
unambiguous assignment by a database search. Sequences which were not positively identified were 
removed from consideration owing to poor specificity. An additional 2 sequences from ACT and 3 
from DNT were removed from consideration as they showed a persistent carryover between runs on 
the nanoLC-MS system. From these initial screening results, the 10 best sequences per protein were 
selected for further evaluation. 
Next, selected “top 10” peptides from ACT and DNT were ordered as crude, heavy labelled 
peptides and spiked into clarified harvest from fermented B. pertussis that was thought to contain 
endogenous ACT, DNT and TCT (Figure 4.4b). Based on co-elution of native and crude heavy 
transitions by PRM, 9/10 ACT sequences were positively detected in the fermenter harvest. In 
contrast, only 5/10 DNT sequences were detected in the unpurified sample, owing to substantially 
lower DNT levels in samples from B. pertussis. Detected ACT and DNT sequences were ranked 
based on native signal intensity with the top 5 sequences per protein chosen for further consideration 
as quantitative standards (Figure 4.4c). 
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Figure 4.4. PRM traces for ACT and DNT synthetic peptides across method optimization 
experiments. A) Chromatogram traces for 33 ACT peptides and 32 DNT peptides screened as 
crude native peptides.  B) Traces from second round of optimization with 10 crude heavy 
labelled peptides for ACT and DNT spiked into unpurified fermenter harvest. C) Final optimized 
traces for ACT and DNT with one peptide for one quantitation (denoted by *) and a 2nd 
sequence for confirmation/specificity (denoted by **). 
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4.3.2 TCT Detection 
 Detection of TCT in unpurified fermenter harvest from B. pertussis was evaluated by 
adding the TCT 1+ and TCT 2+ precursor masses (922.3839 & 461.6985 m/z) to the PRM 
inclusion list used for targeted analysis of ACT and DNT. TCT was positively identified by co-
elution of the 1+ and 2+ precursor masses (Figure 4.5). MS/MS analysis by HCD (Figure 4.5b) 
generated fragment ions matching those previously observed by fast atom bombardment (FAB) 
MS of a TCT homologue in Neisseria gonorrhoeae.183  A signature fragment series from the O-
GlcNAc moiety was also detected with ions at 204, 186, 168, 144, 138 and 126 m/z.184   
 
Figure 4.5. TCT detection in unpurified fermenter harvest from Bordetella pertussis.         
A) Total ion chromatogram from unpurified B. pertussis fermenter harvest. B) MS/MS fragment 
ion spectrum from singly charged TCT precursor. C) Co-elution of intact TCT 1+ (922.3893 
m/z) and TCT 2+ precursor ions (461.6985 m/z). D) Extracted ion chromatograms for TCT 1+ 
transitions favouring fragmentation of the peptide backbone. E) Extracted ion chromatograms for 
TCT 2+ transitions favouring O-GlcNAc (glycan) fragmentation.  
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Figure 4.6. Non-GlcNAc fragments mapped onto TCT structure. Peptide fragments 
correspond to y-ion equivalents (262.1398 & 391.1825 m/z), loss of GlcNAc and oxygen 
(701.2969 m/z), and product of glycan cleavage (516.2306 m/z). 
4.3.3 Targeted Method Refinement 
An underlying assumption in targeted proteomics is that the level of measured peptides is 
a stoichiometric representation of protein levels. After narrowing down to 5 proteotypic 
sequences each for ACT and DNT, this assumption was tested by assessing the quantotypic 
properties of the surrogate sequences. Given the absence of readily available standard, and a 
desire to avoid handling of purified toxins, a peptide-driven strategy with absolutely quantified 
heavy peptide standards was employed in a third round of optimization.  Using lower cost 
Spiketides_TQL (Qtag) standards from JPT Peptides, we were able to retain more sequences in 
quantitative evaluations than what would be feasible give then cost of traditional HPLC-purified 
AQUA peptides. Double heavy Qtag standards were spiked prior to digestion, enabling 
differentiation from single heavy AQUA peptide standards spiked after digestion. By requiring 
enzymatic cleavage to release the double heavy surrogate sequence, the Qtag peptides acted as 
both digestion controls and internal standards for absolute quantitation.  
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 Additional adjustments were made to the Full MS PRM acquisition method to facilitate 
improved detection of targeted ACT, DNT and TCT precursors. First, the number of target 
peptides from ACT and DNT was refined to 5 per protein, and acquisition scheduled with 10 
minute windows. This reduced the number of concurrent precursors to a maximum of 10-12 at 
any given point in the acquisition method. From the savings in duty cycle, it was possible to 
increase the maximum injection time (maxIT) from 100 ms to 300 ms per precursor per target, 
while maintaining collection of 8-10 points across an eluting peak for quantitation. In addition to 
boosting low-level detection, using longer accumulation times also justified increasing the PRM 
resolution from 30, 000 to 120,000, despite the slower Orbitrap scan rate. The higher resolution 
setting makes use of the extended ion accumulation time and provides higher selectively for 
extracted fragment ion chromatogram (XIC) workup. 
 
Figure 4.7. Extracted ion chromatogram traces for residual toxins ACT, DNT and TCT 
detected in-process culture supernatant by targeted nanoLC-PRM analysis. Absolute 
quantitation enabled by spiking matching heavy surrogate peptide standards for ACT and DNT. 
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4.3.4 Digestion Timecourse Analysis  
A digestion timecourse study was used to identify the best performing tryptic peptides for 
absolute quantitation. Doubly heavy Qtag peptide standards were spiked into fermenter harvest 
and analyzed using the refined Full MS PRM method. Given variability in absolute response 
owing to system delivery, the ratios of native-to-heavy (Qtag) peptide standards were monitored 
to assess completeness of proteolytic digestions and obtain a quantitative readout from each 
surrogate sequence. For ACT, two of the sequences, ASALGVDYYDNVR and 
ALQGAQAVAAAQR, showed fast digestion kinetics with stable native-to-heavy ratios. 
However, their quantitative readouts appeared to be outliers relative to the other ACT sequences 
(Appendix 2). One sequence, NIENAVGSAR, showed a gradual increase in signal, stabilizing 
after 4 hours digestion time, whereas the signal for ITGDAQANVLR and INAGADQLWFAR 
dropped in intensity over time.  From these results, NIENAVGSAR displayed the best kinetics 
and stability profile for absolute quantitation. ITGDAQANVLR could be used for confirmation 
and/or specificity (Figure 4.8). Absolute native-to-heavy response for the “top 5” ACT sequences 
and results from a reproducibility assessment are provided in Appendix 2. 
For DNT, 2/5 proteolytic sequences detected contained N-terminal Glutamine and 
Glutamic Acid. Synthesis of Qtag peptide standards was deemed to be unfeasible for 
ELPALIGASGLR and QAFSAASSSAG due to the harsh conditions used to cleave peptides off 
the cellulose membrane in the SPOT synthesis method.182 However, shotgun (DDA) analysis of 
the native peptides spiked post-digestion showed a low relative abundance of pyroglutamic acid 
modifications  (< 5%). This meant the sequences were still viable for use as quantotypic 
standards so long as the pyroglutamic acid modification was adequately controlled.  
 76 
 
Due to the low endogenous level of DNT, there were very limited options for sequences with 
detectable native DNT signal. Therefore, ELPALIGASGLR and QAFSAASSSAG were still 
monitored in the digestion timecourse, normalizing against a consistent concentration of crude 
heavy peptides.  
Spiking the Qtag heavy standards at 5 fmol/µL, only 3/5 DNT sequences were 
confidently detected across the digestion time course based on co-elution of 2+ native peptide 
transitions. One DNT sequence, QAFSAASSSAGR, was observed to drop in signal intensity 
with longer digestion times. Digestion of ELPALIGASGLR and NDDLVSIAATYDR were 
noted to proceed with slower kinetics compare to the more abundant ACT sequences, with a 
gradual rise in signal intensity through 4 hr and 6 hr, respectively. The native-to-heavy ratio for 
ELPALIGASGLR was noted to be more variable across digest triplicates. Therefore, 
NDDLVSIAATYDR was chosen for absolute quantitation, owing to more abundant native signal 
intensity from endogenous DNT and less propensity for modification. ELPALIGASGLR was 
kept as a secondary sequence for confirmation (Figure 4.8). 
 
Figure 4.8. Digestion timecourse results for ACT and DNT surrogate peptides normalized 
against spiked heavy peptide standards. Error bars reflect +/-standard deviation from n=3 
digest replicates per timepoint.   
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TCT signal response was monitored over the digestion timecourse to evaluate stability 
and confirm recovery of the small molecule glycopeptide for multiplexed analysis with protein 
toxins, ACT and DNT. TCT response was noted to be within variability from triplicate digests, 
indicating that TCT is indeed stable during sample preparation (Figure 4.9). The ratio of singly 
to double charged precursor was also observed to be consistent, with the singly charged 
precursors (TCT 1+) being approximately 3-4 fold more intense than the doubly charge TCT 
precursor (TCT 2+). 
  
Figure 4.9. Digestion timecourse results for TCT in unpurified culture supernatant. TCT 
signal was response was confirmed to be within assay variability throughout digestion. Error bars 
reflect ± standard deviation from n=3 replicate measurements per timepoint. 
4.3.5 Method Linearity & Limit of Quantitation 
 Following refinement of surrogate peptides to two sequences per protein, HPLC-purified 
Ultimate AQUA peptides were ordered for the quantitation. Contrary to the Qtag heavy peptide 
standards which were synthesized with two heavy labelled residues, AQUA peptides were 
designed to contain just one heavy, C-terminal residue per sequence. This two-tiered standard 
approach enabled assessment of several key performance metrics including linearity, dynamic 
range, limit of detection (LOD), lower limit of quantitation (LLOQ).   
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 Linearity of response for ACT and DNT peptides was evaluated by spiking heavy 
labelled AQUA peptides into unpurified culture supernatant digests. Matching “double heavy” 
Qtag standards were used to normalized absolute response observed from the “single heavy” 
AQUA peptides over a range from 12.5 amol to 250 fmol on-column. A natural logarithm (ln) – 
ln plot of Qtag-normalized AQUA peptide peak area to AQUA peptide concentration was used 
to correct for heteroscedasticity across the dynamic range (i.e. unequal variability across a range 
of values). NIENAVGSAR from ACT was observed to be linear down to 25 amol on-column 
with a correlation coefficient (R2) > 0.9987. The limit of detection (LOD) was evaluated based 
on co-elution of 2 or more transitions across triplicate digests considering a baseline intensity of 
at least 500 ion counts (as recommended by the vendor, Thermo Scientific). Using 
NIENAVGSAR as a surrogate peptide, the LOD for ACT was measured at 12.5 amol on-
column, corresponding to 2 ng/mL (Figure 4.10). 
 
Figure 4.10. PRM response for 12.5 amol to 250 fmol of ACT AQUA peptide standard 
(NIENAVGSAR). Triplicates analyses plotted for each on-column concentration tested. Peptide 
signal response observed plateau below 25 amol on-column, indicative of loss in linearity. 
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Figure 4.11. Linearity analysis for optimized ACT and DNT AQUA peptides standards. 
Natural logarithm of PRM peak areas from AQUA peptides fit to linear regression equation for 
assessment of lower limit of quantitation (LLOQ). Linearity confirmed from 25 amol to 250 
fmol on-column for NIENAVGSAR (ACT) and 50amol to 250 fmol on-column for 
NDDLVSIAATYDR (DNT). Peptides demonstrate linearity over 5 orders of magnitude dynamic 
range. Triplicates analyses plotted for each on-column concentration tested. 
 
While % CV values for NIENAVGSAR (ACT) were typically less than 5% at the highest 
dilutions, the % CV values for the most dilute concentrations were between 12 and 21 %. This is 
within acceptable limits of variability for a targeted MS assay.185 Therefore the lower limit of 
quantitation (LLOQ) was set at 25 amol on-column (Figure 4.11). 
Comparing the absolute response at equal amounts AQUA peptides, the optimized ACT 
sequences were noted to have approximately 10-fold higher intensity response than the selected 
DNT sequences. Lower absolute peptide response translated into higher limits for DNT in the 
targeted nanoLC-PRM method. The sequence proposed for quantitation, NDDLVSIAATYDR, 
showed linearity down to 50 amol on-column (R2 = 0.9887) with lower detection limit at 25 
amol on-column (Figure 4.11). Variability was notably higher than for ACT with % CV values at 
the exceeding 65% at 25 amol on-column. Considering the range in which the signal was 
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linearity and variability observed at the lowest concentrations tested, the LLOQ for DNT was set 
at 50 amol on-column, equivalent to 4 ng/mL (Figure 4.11). Note - in-solution limits for ACT 
and DNT differ amongst sample types based on starting concentrations and dilutions performed 
prior to LC-MS analysis. 
 
4.3.6 Implementation of the optimized PRM method for simultaneous monitoring of ACT, 
DNT and TCT in samples from Bordetella pertussis 
The optimized nanoLC-PRM method was implemented as an in vitro method for 
measuring toxin levels across culture supernatant (in-process) and final bulk product samples. 
Using NIENAVGSAR for absolute quantitation and ITGDAQANVLR for confirmation, ACT was 
measured in lots of unpurified culture supernatant at 4.0 and 11.5 µg/mL with % CV of less than 5%. 
Following purification, ACT was measured in bulk antigen sample at 3.4 ng/mL and 1.4 ng/mL    
(% CV 34-37%). DNT was measured at 7.9-10.4 ng/mL in culture supernatant (% CV 20-34 %) 
but was not detected in samples post-purification (Tables 4.2-4.3). TCT levels were confirmed to 
decrease during antigen purification; however, absolute quantitation was not possible to the lack 
of an internal reference standard.  Reproducibility was confirmed via assessment digests 
replicates (% CV < 10%) and and day-to-day variability (% CV < 25%) for a given peptide 
sequence. 
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Table 4.2. Quantitative results for B. pertussis toxins in culture supernatant (unpurified 
fermenter harvest) using optimized ACT and DNT Qtag peptide standards. 
 
 
Table 4.3. Quantitative results for B. pertussis toxins in purified antigen using optimized 
ACT and DNT Qtag peptide standards. 
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4.4 Discussion 
The developed targeted MS method can monitor residual toxins levels during downstream 
purification of acellular Pertussis vaccines. Starting in the low µg/mL range in purified fermenter 
harvest, ACT concentrations were observed to decrease ~1000-fold between the culture supernatant 
and purified antigen samples. Considering a 0.5mL vaccine dose, ACT is well below the Ph. Eur. 
regulatory limit of 500 ng per dose.168 For DNT, correlating absence of necrotic lesions to 
concentration value is beyond the scope of this thesis. Nevertheless, DNT removal during purification 
was confirmed with levels dropping from 8-10 ng/mL in culture supernatant to below the LOD in 
purified material (LOD estimated to be 4 ng/mL based on linearity analysis).  
Through the targeted proteomics experiments, it was demonstrated that a synthetic peptide 
screening approach can be applied to accelerate development of a sensitive quantitative MS method 
across samples matrixes of differing complexities.  Though driven initially by a desire to avoid 
working with purified toxins, the principles behind this standard-driven strategy to method 
development are applicable on other circumstances where data driven surrogate selection is not 
always feasible. This includes targeted analysis of novel biomarkers, protein isoforms, and other 
residual impurities from biologics for which there is no readily available protein standard.  
The ability to start assay development without purified reference material represents a key 
advantage over immunochemical-based quantitation methods such as ELISAs. Though widely 
considered the workhorse for HCP testing for recombinant monoclonal antibodies, ELISAs are 
inherently limited by the specificity of the antibody.154,155 Unlike immunochemical methods, targeted 
MS does not require the laborious task of developing and characterizing antibodies as critical reagents. 
Further, effective peptide screening can account for matrix effects, resulting in universally applicable 
assays that can be multiplexed to measure 100s of proteins using one method. 
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Starting on a quadrupole-Orbitrap provided several advantages over traditional SRM/MRM 
development on a triple quad (QqQ) instrument. First, the HRAM capabilities of the Orbitrap 
provided higher resolution MS/MS spectra with simultaneous monitoring of all fragment ions, rather 
than 3-4 transitions per peptide typically monitored by MRM. The ability to toggle between a Full MS 
survey and PRM fragment ion scans in one acquisition method was also particularly helpful when 
working with several sample types. Rather than being blind to salts and detergents commonly found in 
vaccines, the Full MS PRM method provided a high-level snapshot of everything eluting off the 
column. Only a quick visual check of the TIC was needed to evaluate sample complexity and rapidly 
identify deleterious matrix effects.  
In transitioning towards absolute quantitation with the Spiketides_TQL (Qtag) peptides from 
JPT peptides, we benefited from the lower cost of synthesis, and thus were able to consider more 
sequences than would be practical using HPLC-purified AQUA peptide standards. Additionally, the 
option to re-quantitate the Qtag standards by UV spectroscopy immediately prior to analysis is also 
valuable given that heavy peptides would be considered critical standards from a regulatory 
perspective, and thus would be subject to monitoring requirements if implemented in routine use.  
4.5 Conclusion 
 A synthetic peptide screening approach was successfully applied in the development of a 
quantitative targeted MS method for simultaneous quantitation of two residual protein toxins 
(ACT, DNT) and a glycopeptide (TCT) in vaccine intermediates. Digestion timecourse and 
replicate experiments were effective in guiding refinement of surrogate peptide sequences for 
absolute protein quantitation. The versatility of the assay across samples of starkly difference 
complexity demonstrates its value as an in vitro assay that can be employed universally for 
monitoring residual ACT, DNT and TCT in samples from B. pertussis.  
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Chapter 5 – Conclusion & Future Work 
5.1 Conclusion 
The work described above represents successful implementation of MS-based structural 
and quantitative proteomics techniques for analysis of complex biological systems. Electrostatic 
conformational priming effects were characterized for Cyt c-lipid interactions and demonstrated 
the sensitivity of TRESI-HDX for probing transient changes at protein-membrane interfaces. 
Refinement of sample digestion strategies for LC-MS also facilitated more comprehensive 
analysis of vaccine intermediates from Bordetella Pertussis with absolute quantitation of residual 
toxins. A synthetic peptide screening approach also enabled development of targeted MS method 
without access to purified reference material, providing significant advantages over traditional 
immunochemical methods including the ability to multiplex analysis of three residuals in one 
assay. The optimized nanoLC-MS method is ready for deployment in monitoring of residual 
toxins for next generation Pertussis vaccine development. 
5.2 Future Work 
  To complement the results for the Cyt c-lipid interactions, conformational analysis of Cyt 
c in the presence of a membrane mimetic such as nanodiscs could be performed to better 
understand conformational changes occurring due to the surface area of the phospholipid bilayer. 
Additionally, the effect of H2O2, -induced covalent modifications on Cyt c structure could be 
examined by spiking H2O2 into the protein-membrane mixture prior to TRESI-HDX analysis. If 
pre-incubated with Cyt c, MS would be able to confirm of peroxidase activity by monitoring the 
oxidation of CL (+16 Da product). The kinetic TRESI-MS workflow142 could also be used to study 
the kinetics of Cyt c-CL peroxidase catalysis alongside conformational analysis by millisecond 
HDX-MS. In a kinetic TRESI-HDX experiment, H2O2 could be introduced with D2O via the outer 
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capillary to better understand the sequence of conformational transformations required for 
conversion of Cyt c into its peroxidase-active state. Kinetic TRESI-HDX analysis could also be 
used to link structural transitions to functional intermediates in the mitochondrial-induced 
apoptotic pathway. Nevertheless, such HDX-MS experiments would best be performed using 
higher ionic strength buffers that more analogous to physiological conditions.  For TRESI-HDX-
MS, increasing the salt concentration would require refinement of the setup and integration of an 
online desalting apparatus prior to MS analysis.  
 For the residual toxin work, a strategy to evaluate protein-level recovery is needed to 
further assess accuracy of the measurements obtained by targeted nanoLC-MS. This may include 
development of a recombinant protein or concatenated construct such as a QConCAT186 similar 
to the work reported by Health Canada for LC-MS quantitation of flu antigens.187 Coupling a 
protein construct with a digestion control standard would provide better control of sample 
preparation upstream of MS analysis.  
For more routine implementation, the residual toxin method should be transferred to a 
conventional flow LC and triple quad MS. A higher flow targeted (MRM) method would 
improve throughput and robustness, but require bridging to ensure adequate sensitivity for DNT 
detection. Shifting from nanoLC to conventional flow LC would also mitigate limitations of the 
current trap-elute nanoLC setup for hydrophilic TCT. Different column chemistries and LC 
configurations could be evaluated for refined TCT detection while maintaining the ability to 
resolve ACT and DNT tryptic peptides. This work could be performed in parallel with 
establishment of a suitable TCT analogue as a standard for absolute quantitation. A higher 
throughput residual toxin LC-MS method would further facilitate improved characterization of 
acellular Pertussis vaccines.   
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Appendix 
 
Appendix A - Curve Fitting Analysis for Global TRESI-HDX Results 
Fit to exponential Rise to Maximum, Single, 2 Parameter 
f=a*(1-exp(-b*x)) 
 
Parameter Cyt c only Cyt c & DMPC Cyt c & CL 
a 85.74 86.80 53.07 
Std Error a 2.89 1.65 2.41 
b 2.17 5.15 3.29 
Std Error b 0.20 0.53 0.54 
R2 0.99 0.99 0.98 
 
[Constraints] 
b>2 
b<10 
[Options] 
tolerance=1e-10 
1iterations=200 
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Appendix B– ACT quantitation in unpurified culture supernatant using Qtag heavy 
peptide sequences.  
 
 
Protein Sequence 
Qtag Peptide 
Standard 
Concentration 
(fmol/µL) 
Average 
Native-to-
Heavy 
Area 
Ratio 
%CV 
peptide 
(n=9) 
Calculated 
Peptide 
Concentration in 
Sample 
(fmol/µL) 
Calculated 
Protein 
Concentration 
%CV 
Protein 
ACT 
ITGDAQANVLR 
20.0 
0.979 5.2% 44.4 
59.9 fmol/µL 18.8% NIENAVGSAR 1.424 4.7% 64.6 
INAGADQLWFAR 1.560 5.3% 70.8 
DNT NDDLVSIAATYDR 5.0 5.70E-03 20.4% 64.6 64.6 amol/µL N/Ap 
 
 
